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Abstract
The Hedgehog (Hh) and Wnt protein signaling pathways are essential in the differentiation of
neurons and astrocytes. As there are many known and new players involved in regulating
these pathways, the role of the regulators Suppressor of Fused (SUFU) and Never in Mitosis
Kinase 2 (Nek2) have either not been previously reported or have not been thoroughly
explored. To address this shortfall CRISPR gene editing was used to target SUFU and Nek2
in the mouse P19 embryonal carcinoma cell model of neural differentiation. Hh and Wnt
signaling were explored in normal P19 neural differentiation, which occurs in the presence of
retinoic acid. Both pathways are required for the establishment of neural cell fates, however,
neither is sufficient to induce both neurons and astrocyte lineages alone. SUFU was found to
be required in the differentiation of astrocytes, but not neurons, and its loss resulted in the
loss of the Gli3 transcription factor. The loss of Gli3 in SUFU-deficient cells resulted in
constitutive expression of Hh target genes. Nek2 was required for the differentiation of both
neurons and astrocytes, however, loss of function experiments did not find a clear link
between Nek2, and the Hh or Wnt pathways. Instead, a mechanism was discovered where
Nek2 is required to destabilize hypoxia inducible factor 1, allowing for a required metabolic
shift from glycolysis to oxidative phosphorylation during the differentiation of neural cell
types. Together this work shows novel mechanisms of regulating neural cell fate through the
presence or absence of intracellular regulatory proteins.
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Mitosis Kinase 2, Neural Development, Hedgehog Signaling, Wnt Signaling

ii

Summary for Lay Audience
During development, how specific cell types are determined requires the activation of
specific information pathways. Becoming a cell that belongs to the nervous system requires,
in part, activation of the Hedgehog (Hh) and Wnt signaling pathways. The cell types being
explored here were neurons, cells that send and receive electrical impulses, and astrocytes,
cells that support neurons. To answer questions regarding the development of these cell types
a method where cells were grown in a dish that does not require live animals was used. These
stem-like cells comprise the mouse P19 embryonal carcinoma model and were isolated from
a mouse tumor. These cells can become any cell type in the body, and when given the
vitamin A derivative, retinoic acid (RA), can become neurons and astrocytes. Through
chemical studies Hh and Wnt signaling were determined to be essential during neural cell
development. Two proteins involved in regulating these signaling pathways, Suppressor of
Fused (SUFU) and Never in Mitosis Kinase 2 (Nek2), were investigated through loss of
function experiments where a targeted gene editing approach, CRISPR, was used. Loss of
SUFU showed it is vital in the development of astrocytes but not neurons; Nek2 is vital in the
development of both cell types. When SUFU was lost there was over-activation of Hh
signaling, resulting in the loss of Gli3, a transcription factor normally required to inhibit the
Hh pathway. The connection between Nek2, Hh and Wnt signaling pathways were explored,
however, there was no clear evidence showing a link. Instead, Nek2 was found to be
involved in regulating how cells use sugar molecules as without it, the cells metabolize sugar
via a pathway that does not require oxygen. In normal cells, however, the development of
neurons and astrocytes requires a shift from an oxygen-deficient metabolic pathway, to
relying exclusively on one that requires oxygen. Thus, this work sheds new light on how
proteins regulate the development of specific cell types in the central nervous system and
makes connections between signaling pathways, development, and metabolism.
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Chapter 1

1

Introduction

In this chapter I describe what is known and what remains to be explored within the field
of mouse neural differentiation. As a field, mouse neurobiology is vast and encompasses
the establishment of neural structures like the spinal cord and brain during embryogenesis
all the way to replenishing neural cells in the adult brain. Given this large scope, I have
focused my thesis within neural cell type differentiation during embryogenesis.

1.1 Overview
Embryogenesis is a highly complex process that allows a single cell, known as the
zygote, to become an entire animal. This tightly regulated process of cell division, selfrenewal and differentiation is at the core of the fields of development and stem cell
biology. In particular, the process of neural development relies heavily on the stem cell
field to tease apart the intricate protein interactions and genes required for the
establishment of neural cell types. The main classes of cells that exist in the central
nervous system (CNS) are neurons, astrocytes, oligodendrocytes, and microglia (Figure
1-1). Neural cells, including neurons, astrocytes and oligodendrocytes derive from the
ectodermal lineage from a similar pool of neuroepithelial progenitor cells (Bradl 2006).
Neurons are cells that send electrical signals allowing for thoughts, memories, and
movement. Astrocytes form the blood-brain barrier and are vital in providing neurons
with necessary metabolites to function (Mason 2017), regulating synapse formation and
neurotransmitter release from neurons and in neurotransmitter reuptake (Chung et al.
2015). Oligodendrocytes act by increasing the speed of neuron electrical impulses (Nave
and Werner 2014), regulating neuron metabolism and glucose import along axons (Lee et
al. 2012; Saab et al. 2016), and are required for information processing (Moore et al.
2020). Finally, are the microglia that act as the immune system in the brain and are
derived from primitive macrophages of the yolk sac rather than ectodermal lineages of
the embryo (Nayak et al. 2014). In mammals, the establishment of neural cell types
begins during neurulation, the process by which the CNS structures take shape, establish
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the boundaries of various neuron subtypes, and begins the differentiation of glial cells:
astrocytes, and oligodendrocytes.

Figure 1-1: Developmental Origins of Neural Cell Types
Neural ectoderm cells given the proper cues will develop into neural stem cells, which
then become either neurons, astrocytes, or oligodendrocytes. Microglia, although existing
in the brain are not “neural” and are not derived from the same precursor population, are
instead derived from primitive macrophages of the yolk sac that migrate into the CNS
during embryogenesis.
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Neurons, astrocytes, and oligodendrocytes originate from a single pool of cells known as
neural stem cells (NSC) (Vieira et al. 2018). Stem cells, in general, are any cell that can
give rise to themselves, or they can give rise to something new or different. When NSCs
are provided with specific information during neurulation, and throughout nervous
system development, they will become one of these specific cell types. This process,
referred to as differentiation, is defined as the commitment of a cell toward a particular
cell type. However, the “how” and the “when” NSCs should differentiate towards each
lineage is complex and not fully understood. Given the complexity of the embryo, many
researchers have relied on stem cells and their related models to explore the precise
molecular mechanisms involved in regulating the differentiation of these neural cell
types. Becoming a particular cell type during differentiation is dependent on the genes
that the individual cells express. For instance, a neuron will express neuron-specific
genes while an astrocyte will express astrocyte-specific genes.
Given neurons and astrocytes originate from a pool of progenitor cells (Vieira et al.
2018), understanding how different regulatory processes and the accompanying proteins
are involved in this process is vitally important. In this thesis I will present work that
seeks to address some of these unknowns in the cell fate determination of neurons and
astrocytes. Towards that end, I will show how specific proteins, including the Suppressor
of Fused (SUFU) and Never in Mitosis Kinase 2 (Nek2), are required in the process and
will present new connections between protein signaling pathways and neural
differentiation.

1.2

Vertebrate neural development

The development of nervous system tissue is a highly coordinated and complex process
that requires input from multiple cell types and extracellular signals. In vertebrates this
neurulation occurs immediately after gastrulation; the process that establishes the three
germ layers: endoderm, mesoderm, and ectoderm. In vertebrates, neurulation is initiated
from a flat sheet of cells dorsal to the notochord, a mesodermal structure that is essential
in determining the longitudinal axis of the mammalian embryo (Placzek et al. 1990). In
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most vertebrates, primary neurulation factors secreted from the notochord induce the
dorsal sheet to form the floor plate and together these structures instruct the dorsal
ectoderm to fold into the neural tube (Gallera 1971). Deletion and transplantation
experiments in Xenopus and chick embryos demonstrate that the notochord is required to
initiate neurulation, where the presence of two notochords causes the formation of two
floor plates (van Straaten et al. 1985, 1988; Placzek et al. 1990; Yamada et al. 1991)
while the absence of a notochord results in no floor plate formation and no neurulation
(Smith and Schoenwolf 1989; Placzek et al. 1990). While these experiments were
conducted in non-mammalian models, evidence shows that primary neurulation in
mammals is equivalent in reptiles and amphibians (Gallera 1971). Despite these
similarities, a more recent study in human embryos shows the location of neurulation
initiation begins in the middle of the rostral-caudal axis (de Bree et al. 2018). In this
study, neurulation occurred in both directions (de Bree et al. 2018) rather than starting
rostrally and moving towards the caudal end of the embryo as has been reported for
mouse and chicken (Gallera 1971; Nievelstein et al. 1993). Although there are minor
differences between animal species, transplantation experiments in chick highlight that
the process of neural ectoderm induction occurs non-cell autonomously (van Straaten et
al. 1985, 1988; Placzek et al. 1990; Yamada et al. 1991). Thus, cells must be conducted
towards the correct ectodermal cell lineage based on extrinsic signals from the underlying
mesoderm.
Many studies have shown that after the initiation of the floor plate, the dorsal ectoderm
folds to form the neural tube (Figure 1-2). To facilitate this, cells at the medial and
dorsolateral hinge points must restrict their apical surface and expand their basal surface
(Smith and Schoenwolf 1989). Thus, cytoskeletal rearrangements are required for neural
tube folding (Burnside 1973; Rolo et al. 2018), as genetic (Chen et al. 1996; Lesko et al.
2021) and chemical inhibition (Karfunkel 1972) studies involving cytoskeleton
polymerization inhibit neural tube closure. Regulation of cytoskeleton dynamics through
the Wnt planar cell polarity (PCP) pathway are also vital for neural tube folding as
mutations in this and other pathway components lead to neural tube folding defects
(Kibar et al. 2001; Murdoch et al. 2001; Hamblet et al. 2002; Wang et al. 2006a, 2006b).
Closure of the neural tube occurs when the neural folds come together and neural crest
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cells “escape” from the neural tube and give rise to many structures in the face, skull, and
the peripheral nervous system (Golden and Chernoff 1993). In mice and humans, unlike
in birds, there are multiple sites of initiation of neural tube closure along the rostralcaudal axis (Golden and Chernoff 1993; Van Allen et al. 1993), and a failure in closure
results in multiple developmental diseases including non-lethal spina bifida, and lethal
anencephaly (Van Allen et al. 1993; Juriloff and Harris 2000).
Signals essential for neural tube formation include members of the Fibroblast Growth
Factor (FGF), Hedgehog (Hh), Bone morphogenic protein (BMP), Notch/Delta families
and retinoic acid (RA). FGF is secreted from cells of the neural tube organizer that
demarcate the location of the caudal stem zone, as it moves along the rostral-caudal axis
(Mathis et al. 2001; del Corral et al. 2002). As cells move through and exit the organizer,
they stop expressing Fgf8 allowing them to become notochord and floor plate (del Corral
et al. 2002). Notch/Delta signaling is important in the formation of floor plate versus
notochord as these cells exit the organizer, where active Notch signaling induces floor
plate specification (López et al. 2003; Gray and Dale 2010; Stasiulewicz et al. 2015). The
notochord secretes Sonic Hedgehog (SHH) which can also induce floor plate formation
that, in turn, also secretes SHH into the developing neural fold (Yamada et al. 1991;
Echelard et al. 1993; Krauss et al. 1993). Although SHH is secreted from the notochord,
Shh expression is only required for notochord maintenance after induction, as Shh-/- mice
can form a notochord but the structure is lost as the organizer moves caudally over time
(Chiang et al. 1996). These experiments did, however, show that Shh is required for floor
plate induction as no floor plate is observed in mice lacking Shh (Chiang et al. 1996) or in
mice treated with antibodies blocking SHH activity (Ericson et al. 1996). SHH secretion
establishes a morphogen gradient along the dorsal-ventral axis that is essential in the
development of ventrally located motor and interneurons (Ericson et al. 1996, 1997).
Despite Shh being absolutely required for motor neuron differentiation, some adjacent
classes of interneurons along the dorsal-ventral axis form in the Shh-/- mouse (Litingtung
and Chiang 2000). The role of Shh in the dorsal-ventral axis was primarily observed by
the expression of Shh target genes or by immunostaining of fixed tissues (Gritli-Linde et
al. 2001; Huang et al. 2007) and was not until the use of GFP-tagged SHH, was the
ligand confirmed to be within the neural pore (Chamberlain et al. 2008).
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Figure 1-2: Neural tube folding
The notochord secretes SHH to induce the induction of the floor plate and the formation
of the neural fold. Dorso-lateral hinge points cause opposing sides of the neural fold to
come together to form the roof plate. BMP from the roof plate and SHH from the floor
plate establish the dorsal-ventral axis creating distinct regions of motor neurons,
interneurons, and sensory neurons. These regions are fine-tuned by the secretion of RA
from somites. After roof plate formation the surface ectoderm detaches from the neural
ectoderm as newly formed neural crest cells begin to migrate. Image created with
Biorender.com.
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Dorsally secreted BMP is in opposition to ventrally secreted SHH. The dorsal ectoderm
secretes BMP as the neural folds come together from opposing sides to form the roof
plate (Basler et al. 1993; Liem et al. 1995), where BMPs are essential in establishing
dorsal sensory neurons and interneurons (Lee et al. 1998, 2000; Millonig et al. 2000).
Loss of BMP family members (Lee et al. 1998, 2000), the inhibition of BMP by secreted
antagonists (Chesnutt et al. 2004) and/or the loss of BMP receptors (Wine-Lee et al.
2004) results in the loss of dorsal-most sensory and interneurons. In contrast, BMP
overexpression expands dorsal interneuron regions (Panchision et al. 2001; Timmer et al.
2002). BMP is also required to induce expression of canonical Wnt ligands 1 and 3 (Parr
et al. 1993; Wine-Lee et al. 2004) allowing for fine-tuning of dorsal interneuron
populations (Muroyama et al., 2002) and to expand the number of dorsal interneuron
progenitors (Ikeya et al. 1997; Chesnutt et al. 2004). Fine-tuning of neuron populations is
controlled dorsally through Wnt expression but is primarily through the secretion of RA
from the paraxial, or somitic mesoderm (Maden et al. 1998; Berggren et al. 1999; del
Corral et al. 2002; Molotkova et al. 2005). In support, embryos lacking RA or the RA
producing enzyme RALDH2 have abnormal neural tubes, particularly lacking dorsal
regions, and show decreased neuron differentiation (del Corral et al. 2003; Wilson et al.
2003, 2004; Molotkova et al. 2005). Removing RA from the developing neural tube also
reduces Bmp4, Bmp7, Wnt1 and Wnt3a expression, coinciding with the loss of dorsal
neural cell fates and highlighting the vital role of RA in dorsal patterning (Wilson et al.
2004). Conversely, ventral neuron regions are expanded in the RA-deficient embryo, thus
RA antagonizes ventral cell fates (Wilson et al. 2004). The distance of cells from the
SHH or BMP source determines their responsiveness to RA, determines their gene
expression profiles and interneuron cell fates. For example, ventral SHH induces the
expression of the ventral interneuron transcription factor Nkx2.2, while RA induces the
expression of Pax6, a transcription factor that inhibits Nkx2.2 expression (Wilson et al.
2004; Schäfer et al. 2005). The interactions, both positively and negatively, between
these signaling pathways and their downstream targets create gene regulatory networks
that allows for the formation of very specific regions of neuron cell identity.
Not only is the specificity of neuron cell fate instructed by these signals along the dorsalventral axis, but it also exists along the rostral-caudal axis. This is particularly important
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for motor neuron populations that have different developmental requirements along the
trunk of the developing embryo. FGF and RA are used again along the rostral caudal axis
to induce the expression of Hox genes (Liu et al. 2001; Bel-Vialar et al. 2002). Thus, the
determination of distinct neural tube populations along multiple axes is a complex
interaction of morphogen gradients that not only establishes these cell type regions, but
also are involved in the differentiation of distinct cell fates.
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1.3
1.3.1

Protein signaling pathways in neural differentiation
Hedgehog signaling in neural differentiation

Hedgehog (Hh) signaling (Figure 1-3), as described in Section 1.2, is important in the
dorsal-ventral patterning of the vertebrate neural tube but also, in the anterior-posterior
patterning of the vertebrate limb (Riddle et al. 1993; López-Martínez et al. 1995), the
medial-proximal axis of the developing face (Hu and Helms 1999; Dworkin et al. 2016)
and in determining neural cell identity (Ericson et al. 1996, 1997; Belgacem et al. 2016;
Brady and Vaccarino 2021; Yang et al. 2021). The pathway begins following the
secretion of a Hh ligand, either Indian Hedgehog (IHH), Desert Hedgehog (DHH) or
SHH. IHH is involved in bone development and hematopoiesis (St-Jacques et al. 1999;
Dyer et al. 2001), whereas DHH is involved in male germline development (Bitgood et
al. 1996; Clark et al. 2000). SHH, as indicated above, is the ligand involved in neural
development (Ericson et al. 1996, 1997; Belgacem et al. 2016; Brady and Vaccarino
2021; Yang et al. 2021) and despite it being the ligand reported in vivo, some in vitro
studies have shown increased expression of all three ligands with neural induction (Wu et
al. 2010; Spice et al. 2022b).
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Figure 1-3: Hedgehog Signaling
In the absence of a Hh ligand, the Ptch receptor blocks the translocation of Smo into the
primary cilium. The negative regulator of signaling, SUFU either sequesters full-length
Gli2 in the cytoplasm or promotes the phosphorylation of Gli3 by PKA, GSK3 and CK1.
Phosphorylated Gli3 is ubiquitinated and partially degraded by the proteosome to form a
transcriptional repressor (Gli3R) to block target gene transcription. Gli3R blocks
transcription as partial degradation removes the transactivation domain observed in fulllength Glis leaving only its repressor domain active (Hui and Angers 2011). The presence
of a Hh ligand inhibits Ptch removing it from the plasma membrane, allowing Smo into
the primary cilium, which causes SUFU to dissociate from full-length Gli. Following
this, Gli translocates to the nucleus and activates the transcription of target genes like
Ptch1 and Gli1. Image created with Biorender.com with reference to (Briscoe and
Thérond 2013).
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Before being secreted Hh ligands must undergo post-translational modifications to be
fully functional (Lee et al. 1994; Pepinsky et al. 1998; Taylor et al. 2001). Hh enters the
endoplasmic reticulum (ER) and the immature ligand undergoes autoproteolytic cleavage
where a cholesterol group is added and the C-terminal end of the protein is removed
(Figure 1-4) (Lee et al. 1994; Ekker et al. 1995; Porter et al. 1995, 1996; Chen et al.
2011a). The C-terminal end of SHH is transported out of the ER and is degraded by the
proteasome (Chen et al. 2011a), whereas the cholesterol modified N-terminus (N-SHH) is
the active form of the protein. This cleavage is required as mutations in the processing
region of Hh causes reduced neural induction (Lai et al. 1995) and holoprosencephaly, a
failure of the forebrain to divide during brain development (Roessler et al. 1996, 2009;
Traiffort et al. 2004; Maity et al. 2005). This active form is found in the neural tube and
induces neuron differentiation (Fan et al. 1995; Hynes et al. 1995; Lai et al. 1995; Marti
et al. 1995; Porter et al. 1995; Roelink et al. 1995). The lipidation on the C-terminal end
of N-SHH, is accompanied by modification of the N-terminus with palmitic acid
(Pepinsky et al. 1998). This second lipid addition is essential for function, as the nonlipidated form of the protein has an approximately 160-fold decrease in pathway activity
compared to the palmitoylated version (Taylor et al. 2001; Maity et al. 2005).
Palmitoylation occurs by Skinny Hedgehog or rasp in Drosophila (Chamoun et al. 2001;
Micchelli et al. 2002), or Hedgehog acyltransferase (Hhat) in mammals (Buglino and
Resh 2008, 2010). The site of modification occurs in the ER (Konitsiotis et al. 2015), and
this modification is required for enhancing the activity of the ligand on receiving cells, its
stabilization after secretion and its ability to form soluble multimers (Gallet et al. 2003;
Chen et al. 2004; Peters et al. 2004; Callejo et al. 2006; Goetz et al. 2006; Grover et al.
2011). In mouse embryos, Hhat loss of function causes reduced SHH activity,
corresponding to loss of floor plate and interneuron populations and holoprosencephaly
(Dennis et al. 2012; Iulianella et al. 2018). Interestingly, the loss of floor plate and
interneuron populations in Hhat loss of function embryos is rescued by mutations in the
Patched (Ptch) receptor (Iulianella et al. 2018).
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Figure 1-4: Hedgehog ligand modifications
In the endoplasmic reticulum, cholesterol causes the autoproteolytic cleavage of the Cterminal end of the HH protein before Hedgehog acyltransferase (Hhat) adds a palmitic
acid to the N-terminal end. This lipid-modified and cleave ligand is then prepared for
secretion through multiple mechanisms including being incorporated into the cell surface,
being packaged into multi-protein particles, and being excreted on the surface of
exosomes. Image created using Biorender.com with reference to (Briscoe and Thérond
2013).
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Secreted SHH also requires the membrane protein Dispatched (Ma et al. 2002), which
recognizes the cholesterol modification and transfers N-SHH to the secreted protein
SCUBE2, shielding the cholesterol from the aqueous environment of the extracellular
space (Creanga et al. 2012; Tukachinsky et al. 2012). Following secretion and diffusion,
cells respond when SHH binds to its receptor Ptch (Ingham et al. 1991; Marigo et al.
1996; Stone et al. 1996), where Ptch inhibits Smo in the absence of ligand (Chen and
Struhl 1996; Taipale et al. 2002), participates in limiting Hh diffusion (Chen and Struhl
1996; Briscoe et al. 2001) and together with the Hh co-receptor, Hedgehog interacting
protein (Hip), bind the Hh ligand (Chuang et al. 2003). However, the Ptch-Hip1
interaction is not essential for neural development as Hip1 loss of function mice have
normal neural tubes (Chuang et al. 2003). Other receptors of SHH include CDO, BOC,
GAS1, various glypicans and LRP2 (Tenzen et al. 2006; Allen et al. 2007; Yan and Lin
2009; Christ et al. 2012). Glypicans can promote or inhibit Hh activity (Yan and Lin
2009; Williams et al. 2010) whereas LRP2 promotes Hh transduction and is required to
transduce Hh signaling in the developing mouse forebrain (Christ et al. 2012). CDO,
BOC and GAS1, unlike Ptch, promote Hh signal transduction (Tenzen et al. 2006; Allen
et al. 2007) and all three are required in the neural tube as triple knockout embryos show
complete loss of ventral neurons (Allen et al. 2011). In vertebrates there are two Ptch
paralogues, Ptch1 and Ptch2, both of which are Hh target genes and participate in a
negative feedback loop to sequester Hh after pathway activation (Chen and Struhl 1996;
Concordet et al. 1996; Goodrich et al. 1996, 1999; Hepker et al. 1997). Ptch activity is
required for neural development and its loss of function leads to neural tube closure
defects (Goodrich et al. 1997). Ptch overexpression also causes embryonic or early
postnatal lethality with an expansion of dorsal interneuron populations and neural tube
closure defects (Goodrich et al. 1999).
Suppressor of Fused (SUFU), a focus of the presented work, is a negative regulator of
Hh. SUFU acts by either sequestering full length Glis in the cytoplasm, thus inhibiting
their nuclear translocation, or promotes their conversion to a transcriptional repressor
(Chen et al. 2009; Humke et al. 2010). When Hh is present the SUFU-Gli complex is
recruited into the primary cilium where SUFU dissociates from the full-length form of
the Gli activator (Haycraft et al. 2005; Humke et al. 2010; Tukachinsky et al. 2010; Chen
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et al. 2011c). Kinesin-like family members are involved in this activation as the
EVC/EVC2 proteins bind Smo and this complex recruits the microtubule motor protein
Kif7 in the primary cilium (Yang et al. 2012). Other intraflagellar transport proteins
(IFTs) (Haycraft et al. 2005) are involved as the dissociation of SUFU from Gli3 and the
activation of the latter is also dependent on the IFT, Kif3a (Humke et al. 2010).
Recruitment of Kif7 may be the key connection between Smo and SUFU as reducing the
amount of SUFU restores the lost Hh activity and floor plate development observed in the
Kif7-/- embryo (Law et al. 2012). The loss of function of IFT88 in the midbrain of the
E9.0 mouse embryo also causes a complete loss of Hh activity and reduced dopaminergic
neuron differentiation like Gli2-/-/Gli3-/- double mutants (Gazea et al. 2016).
Smo transduction of the Hh signal does not solely rely on IFT proteins, as cAMPdependent Protein Kinase A (PKA) and casein kinase 2 (CK2) in Drosophila (Jia et al.
2010; Li et al. 2014), and casein kinase 1 (CK1) and GPCR kinase 2 (Grk2) in vertebrates
(Chen et al. 2011b) also play a key role. For instance, Smo mutations that simulate
constitutive phosphorylation of its cytoplasmic tail is sufficient to expand ventral neuron
regions in the chick neural tube (Chen et al. 2011b). Grk2 is known to promote
neurogenesis in the PC12 model of neuron differentiation, however, the link between
Grk2 and Hh signaling was not explored in this study (Karkoulias et al. 2020). Some
evidence also points to the role of CK2 and mouse neural development, where CK2-/mutants have open neural tubes (Lou et al. 2008; Dominguez et al. 2011). However, these
reports, like that with Grk2, have not made the connection between neural development
and Hh signaling. Some of these kinases also play an essential role in regulating SUFU
and Gli proteins downstream of Smo. PKA and glycogen synthase kinase 3 (GSK3)
phosphorylate and stabilize SUFU (Chen et al. 2011c) where protein phosphatase 4
dephosphorylates SUFU in response to SHH (Liao et al. 2020). Studies have found that
active Hh signaling targets SUFU for proteasomal degradation (Yue et al. 2009),
however, we have found no changes in SUFU levels during neuron differentiation despite
active Hh signaling (Chapter 2) (Spice et al. 2022b). Likewise, others have shown that
SUFU is required for maximal Hh pathway activation in developing ventral neuron
identities in the neural tube (Zhang et al. 2017). In fact, SUFU is essential during neural
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tube development, as Sufu-/- embryos are embryonic lethal due to heart and neural tube
closure defects (Cooper et al. 2005). In addition, loss of SUFU function decreases retinal
neuron differentiation (Cwinn et al. 2011), reduces and delays cerebellar neuron
differentiation (Kim et al. 2018) and is critical in timing the differentiation of projection
neurons in the mammalian neocortex (Yabut et al. 2015). SUFU also reduces and delays
astrocyte differentiation in vitro (Chapter 2) (Spice et al. 2022b) and is required for
oligodendrocyte differentiation in the mouse forebrain (Winkler et al. 2018). These
defects all support the fact that SUFU primarily acts as a negative regulator of Hh
signaling as SUFU-deficient cells and embryos show constitutive expression of Hh target
genes (Cooper et al. 2005; Svärd et al. 2006; Chen et al. 2009; Wu et al. 2010; Hoelzl et
al. 2015, 2017; Yabut et al. 2015; Urman et al. 2016; Spice et al. 2022b). Additionally,
the phosphorylation status of SUFU is critical for conferring the Hh response, as SUFU
stabilization and phosphorylation can both inhibit and promote Hh target gene expression
(Takenaka et al. 2007; Chen et al. 2011c). For example, ubiquitination of SUFU on
Lys63 increases its association to Gli3 and promotes Gli3 conversion to a repressor
(Infante et al. 2018), while other ubiquitinated sites reduce SUFU association to Gli1 and
promote Hh signaling (Raducu et al. 2016). Thus, more context-specific evidence is
needed to demonstrate the changes in SUFU post-translational modifications throughout
neural differentiation to better understand how the presence or absence of Hh alters the
activity of SUFU regulating kinases and ubiquitinating proteins.
What is clear, is that SUFU plays a key role in Gli transcription factor regulation, and that
it primarily acts as a negative regulator of these factors. In vertebrates there are three Gli
proteins, Gli1, Gli2 and Gli3. Gli1 acts solely as an activator as it is missing the Nterminal repressor domain while Gli2 and Gli3 can act as either activators or repressors
(Dai et al. 1999; Sasaki et al. 1999). Despite the similarity between Gli2 and Gli3, they
do have distinct roles within vertebrate Hh signaling. Gli2 primarily acts as the
transcriptional activator, whereas Gli3 is the transcriptional repressor (Altaba 1998; Bai
et al. 2002; Buttitta et al. 2003; Motoyama et al. 2003). Interestingly, in zebrafish and
amphibians, who also possess three Gli proteins, Gli1 acts as the primary activator of
signaling instead of Gli2 (Lee et al. 1997; Altaba 1998; Karlstrom et al. 2003; Ke et al.
2008). Nevertheless, SUFU acts to regulate Gli proteins, and it is well known that it
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sequesters Gli transcription factors in the cytoplasm (Ding et al. 1999; Barnfield et al.
2005; Chen et al. 2009; Humke et al. 2010). SUFU also promotes the conversion of Gli
proteins to transcriptional repressors (Chen et al. 2009; Humke et al. 2010) by protecting
them from SPOP-Cul3 mediated ubiquitination and degradation (Chen et al. 2009; Wang
et al. 2010) and recruiting GSK3, PKA and CK1 to phosphorylate Gli proteins (Jia et al.
2005; Tempe et al. 2006; Wang and Li 2006; Pan et al. 2009). This phosphorylation
recruits other ubiquitin ligases to cause partial proteasomal degradation, converting Gli to
a repressor through -TrCP-mediated ubiquitination (Jia et al. 2005; Wang and Li 2006;
Wen et al. 2010). Gli3 is converted to the transcriptional repressor through
phosphorylation (Tempe et al. 2006; Wang and Li 2006), while Gli2 phosphorylation
typically results in total degradation of the protein (Bhatia et al. 2006; Pan et al. 2006).
Lastly, SUFU can regulate Gli transcriptional activity by interacting with SAP18 and
DNA-bound Gli3 to increase repressive activity (Cheng and Bishop 2002; Paces-Fessy et
al. 2004). Gli proteins can also undergo sumoylation, another post-translational
modification, that increases their activator activity in vitro, and in the mouse neural tube
(Cox et al. 2010). Together these interactions regulate the transcriptional response of cells
to Hh ligands, but how these occur following Hh activation is complex.
All three Glis have a conserved DNA-binding sequence (Kinzler and Vogelstein 1990)
that exist upstream of signaling targets, including Ptch1, Ptch2, and Hhip (Ågren et al.
2004; Vokes et al. 2007; Lee et al. 2010) to promote a negative feedback mechanism.
Gli1 and Boc (Lee et al. 1997, 2010; Dai et al. 1999; Vokes et al. 2007) promote a
positive feedback mechanism of these same signaling targets. Regardless of the
mechanism, Gli proteins are essential in neural development as Hh signaling is lost and
neural tube defects are present in Gli2-/-/Gli3-/- embryos (Buttitta et al. 2003; Motoyama
et al. 2003; Gazea et al. 2016) and in embryos with only one defective Gli (Ding et al.
1998). Despite Gli1 being a Hh target gene, it is not required for neural development as
Gli1-deficient embryos have no neural defects (Park et al. 2000; Bai et al. 2002). Given
the role of SHH in neural tube development and differentiation of ventral interneuron and
motor neuron populations, it is not surprising that neural inducing transcription factors
are also targets of Gli proteins (Motoyama et al. 2003; Lei et al. 2006; Vokes et al. 2007;
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Voronova et al. 2011; Peterson et al. 2012). As shown previously, Gli activation
promotes the expression of pan-neuron inducing factor Ascl1/Mash1 (Voronova et al.
2011; Spice et al. 2022b), pan-neural factor Sox2 (Takanaga et al. 2009; Peterson et al.
2012; Bora-Singhal et al. 2015), and ventral interneuron markers Nkx2.2 (Lei et al. 2006;
Vokes et al. 2007; Peterson et al. 2012) and FoxA2 (Motoyama et al. 2003; Vokes et al.
2007; Peterson et al. 2012). Expression of neural-related target genes also relies on the
removal of the Gli-repressor, which is sufficient for expression of the ventral interneuron
marker Nkx6.1 (Wijgerde et al. 2002; Lebel et al. 2007; Peterson et al. 2012) and motor
neuron marker Olig2 (Peterson et al. 2012). Thus, embryos lacking all three Gli proteins
are capable of inducing motor neuron differentiation (Bai et al. 2004).
Hh signaling (schematic in Figure 1-3) is well known to play a vital role in neural
development, and experiments involving neural differentiation and neural tube
morphogenesis have been instrumental in determining the molecular mechanisms of the
pathway. Loss of function experiments have highlighted the necessary roles of Hh
pathway components in neural development, however, given the complexity of Hh
signaling and the various times during neurogenesis that a Hh signal is required, there are
still many unanswered questions. My work aimed to answer some of these questions by
exploring loss of SUFU and Never in Mitosis Kinase 2 (Nek2) in neural differentiation in
the P19 model, and I provide evidence that the negative regulation of Hh signaling is
required for this differentiation.
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1.3.2

Wnt signaling in neural differentiation

Wnt signaling (Figure 1-5), like Hh, is absolutely required for normal neural development
as it acts to differentiate specific dorsal interneuron populations, increasing the number of
dorsal neuron progenitors, and establishing the midbrain (McMahon et al. 1992; Ikeya et
al. 1997; Muroyama et al. 2002; Chesnutt et al. 2004; Gibbs et al. 2017). Wnt signals are
also required for in vitro neuron differentiation where its activation favors the
specification of neurons over astrocytes (Smolich and Papkoff 1994; Tang et al. 2002;
Spice et al. 2022a). Unlike Hh, that acts as a long-range morphogen of the developing
central nervous system, Wnt ligands have more restricted expression along the dorsalventral axis and are induced through active BMP (Parr et al. 1993; Wine-Lee et al. 2004).
Wnts were first discovered in 1982 (Nusse and Varmus 1982) and since then 19
mammalian Wnt ligands and at least 10 receptors have been described (Wang et al. 2012;
Nusse and Clevers 2017). Given the number of ligands available to cells for signaling, it
is not surprising that different Wnt-Wnt receptor combinations elicit some distinct
pathway responses (Dijksterhuis et al. 2015), and ligands act alone or synergistically to
activate the canonical Wnt--catenin pathway (Najdi et al. 2012; Alok et al. 2017).
A parallel to Hh is the similar lipid modification observed on Wnt ligands, although with
slight differences. Hh ligands are modified with cholesterol and palmitic acid (Lee et al.
1994; Ekker et al. 1995; Porter et al. 1995, 1996; Pepinsky et al. 1998; Chen et al. 2011a)
while Wnt ligands are modified with palmitoleic acid, a derivative of palmitic acid
(Willert et al. 2003; Zhai et al. 2004; Takada et al. 2006; Doubravska et al. 2011). The Oacyltransferase responsible for Wnt modification is Porcupine (Porc), that modifies Wnt
ligands in the ER (Kadowaki et al. 1996; Zhai et al. 2004; Rios-Esteves et al. 2014).
Lipid modification of Wnt is believed to restrict their diffusion from producing cells, as
overexpression of Porc in the chick neural tube decreases the range of Wnt-induced
proliferation of dorsal interneuron progenitors (Galli et al. 2007). Lipid modification is
required for Wnt secretion (Takada et al. 2006; Doubravska et al. 2011). This
hydrophobic region likely facilitates Wnt incorporation into lipoprotein particles
(Panáková et al. 2005), or on the extracellular surface of secretory vesicles, exosomes,
and the plasma membrane (Gross et al. 2012; Farin et al. 2016; McGough and Vincent
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2016). Shuttling of Wnt into these secretory vesicles and to the plasma membrane is
performed by Wntless/Evi (Wls) (Bänziger et al. 2006; Gross et al. 2012; Najdi et al.
2012). Wls is essential for pathway activity as the loss of its activity inhibits Wnt
pathway activation and Wls-conditional null alleles phenocopy Wnt-1 loss of function
(Bänziger et al. 2006; Carpenter et al. 2010). More work is needed, however, to fully
understand the role of Wls and Porc in neural development and differentiation as Porc-/embryos are lethal at gastrulation and heterozygotes do not show neural abnormalities
(Barrott et al. 2011; Biechele et al. 2011).
Lipid modification of Wnt is not only required for its secretion but it is also necessary for
interacting with its primary receptor Frizzled (Fzd) (Janda et al. 2012). In the presence of
Wnt, Fzd dimerizes with the Wnt co-receptor LRP5/6 (Pinson et al. 2000; Tamai et al.
2000; Janda et al. 2017) that acts to recruit the scaffolding proteins Disheveled (Dvl) and
Axin to the plasma membrane (Schwarz-Romond et al. 2007; Fiedler et al. 2011;
Tauriello et al. 2012). As Fzd directly interacts with Dvl (Tauriello et al. 2012) it is
thought that Wnt causes Fzd-LRP5/6 dimerization that then recruits Dvl, which acts as a
platform for Axin interaction with the cytoplasmic tail of LRP5/6 (Mao et al. 2001b). All
these interactions, however, require the activation of kinases, GSK3 and CK1 (Tamai et
al. 2004; Zeng et al. 2005), proteins also involved in transmitting the Hh signal. Given
the role of Wnt in the development of dorsal neurons, it is not surprising that Fzd10 has
been identified in the dorsal neural tube of Xenopus, and that its overexpression increases
the number of sensory neurons (Garcia-Morales et al. 2009). Incidentally, in vitro
differentiation of neurons is also enhanced by the overexpression of Fzd10 (GarciaMorales et al. 2009). LRP6 is also essential in neural development as its loss causes
midbrain defects, a reduction in dorsal interneurons in the neural tube and it inhibits the
differentiation of dopaminergic neurons (Pinson et al. 2000; Castelo-Branco et al. 2010;
Gray et al. 2013). In contrast, CDO, which interacts with and inhibits LRP6, loss during
in vitro neuron differentiation increases Wnt signaling and inhibits neuron differentiation
(Jeong et al. 2014). The loss of either Wnt1 or LRP6 increases neuronal differentiation of
mouse embryonic stem cells (mESC) (Čajánek et al. 2009) yet others have shown
increased neuron differentiation with Wnt activation (Smolich and Papkoff 1994; Tang et
al. 2002; Spice et al. 2022a). However, a contradiction exists showing decreased neuron
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differentiation when both Fzd and LRP6 are inhibited in human embryonic stem cell
(hESC) derived neurogenesis (Bengoa-Vergniory et al. 2017). Although there are
discrepancies, it is apparent that Wnt signaling and thus the presence and activity of Wnt
receptors is crucial to the differentiation of neural cells.
When Wnt is present, it causes the recruitment of Dvl and Axin to interact with the
intracellular domains of LRP5/6 and Fzd (Mao et al. 2001b; Schwarz-Romond et al.
2007; Fiedler et al. 2011; Tauriello et al. 2012). This recruitment of Axin to the plasma
membrane causes the disassembly of the destruction complex (Roberts et al. 2011; Kim
et al. 2013) and the stabilization, cytosolic accumulation, and nuclear import of -catenin
(Li et al. 2012). Although disassembly of the destruction complex is the commonly held
belief, in some contexts Axin remains bound to -catenin with Wnt activation allowing
newly synthesized -catenin to accumulate (Li et al. 2012). GSK3 activity or its ability
to interact with the destruction complex is also suggested to be inhibited by
phosphorylated LRP5/6 (Stamos et al. 2014). Axin overexpression during neural
development in vivo causes the complete loss of midbrain structures (Yu et al. 2007) and
reduced neuron differentiation in the neocortex (Hirabayashi et al. 2004). This is also
supported in vitro as its overexpression or chemical stabilization in P19 cells or primary
mouse NSC cultures inhibited the differentiation of neurons (Lyu et al. 2003; Hirabayashi
et al. 2004; Spice et al. 2022a). Conversely, when GSK3 is chemically inhibited reports
show increased Wnt signaling activity and increased neuron differentiation at the expense
of astrocyte differentiation (Lange et al. 2011; Spice et al. 2022a). However, another
report shows decreased neuron differentiation when GSK3 is knocked out (Kim et al.
2009). Thus, like other players, discrepancies are noted and are likely the result of how
the investigations were performed. Nonetheless, the absence of a Wnt ligand promotes
the degradation of -catenin (Xing et al. 2003; Kohler et al. 2009; Pronobis et al. 2015),
which is phosphorylated by CK1 and hyperphosphorylated by GSK3 (Liu et al. 2002).
These post-translational modifications, along with GSK3 phosphorylating APC, allow the
recruitment of the -TrCP E3 ubiquitin ligase complex leading to the proteasomal
degradation of -catenin (Aberle et al. 1997; Pronobis et al. 2015).
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Wnt pathway activation leads to the transcription of target genes as -catenin in the
nucleus interacts with T cell Factor/Leukemia Inhibitory Factor (TCF/LEF); a family of
transcription factors (Behrens et al. 1996; Molenaar et al. 1996). -catenin facilitates this
interaction as TCF is known to bind to the inhibitory protein Groucho in the absence of
Wnt (Cavallo et al. 1998; Roose et al. 1998). Targets of active Wnt signaling include cell
cycle regulators c-Myc and cyclin D (He et al. 1998; Tetsu and McCormick 1999), and
negative feedback genes Dickkopf-1 (Dkk1) (Niida et al. 2004), that acts to bind and
inhibit LRP5/6 (Mao et al. 2001a), Disabled-2 (Dab2) (Railo et al. 2009), that acts as an
Axin stabilizer (Jiang et al. 2009), and Axin (Lustig et al. 2002). TCF transcription factors
have been explored sparingly in neural development, however, it has been reported that
the overexpression of a dominant-repressor form of TCF in the chick neural tube
promotes oligodendrocyte differentiation (Ye et al. 2009).
Although the canonical Wnt signaling pathway (Figure 1-5) plays a role in neural
precursor cell proliferation and neural lineage differentiation, not all pathway
components have been explored within the neural context. As major players in Wnt
signaling also regulate Hh signaling, and that both pathways play various roles in neural
development, more work is required to tease apart this crosstalk. Toward this end, I
sought to explore Nek2 as a potential node of crosstalk between Wnt and Hh signaling
within P19 neural differentiation. Although results presented herein do not show that
Nek2 acts in this manner, they do show that Nek2 does promotes Wnt signaling during
neural differentiation, and its overexpression phenocopies the loss of astrocytes observed
with chemical overactivation of Wnt signaling.
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Figure 1-5: Wnt Signaling
In the absence of Wnt ligand the destruction complex including CK1, GSK3, Axin and
APC, causes the hyperphosphorylation of -catenin. -catenin phosphorylation causes it
to be degraded by the proteosome. During canonical signaling, Wnt binds the coreceptors LRP5/6 and Frizzled, which leads to the recruitment of Disheveled to the
plasma membrane. This translocation subsequently causes the recruitment of Axin and
the dissociation of the -catenin destruction complex, which allows the latter to
accumulate and translocate to the nucleus. Here, -catenin interacts with TCF/LEF
transcription factors to promote the transcription of target genes like Dab2 and Dkk1.
Image created with Biorender.com with reference to (Nusse and Clevers 2017).
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1.3.3

Other signaling pathways involved in neural differentiation

Although not explored in the presented work, it is important to note other signaling
pathways also have central roles in neural development, as described in Section 1.2, and
pattern neural cell fate. These include the Notch/Delta signaling pathway (Figure 1-6),
which works through a juxtacrine mechanism where the ligand Delta/Jagged binds the
extracellular domain of the Notch receptor. This binding allows -secretase to cleave and
activate the intracellular domain of Notch (NICD) (Yoon and Gaiano 2005). NICD then
enters the nucleus where it activates transcription by interacting with CBF1,
recombination signal binding protein J and Mastermind (Griffin et al. 2000; Yoon and
Gaiano 2005). The overarching view of Notch signaling within neurogenesis is that
active Notch maintains cells in a neural progenitor fate and that inhibition of Notch
induces neuron differentiation. Notch does this through promoting the expression of the
Hes transcription factors (Ryoichiro and Ohtshuka 1999) that act to inhibit the expression
of neural-inducing genes like Ascl1/Mash1 (Bertrand et al. 2002). The requirement of
Notch for neural progenitor maintenance has been confirmed through many studies
showing early and increased neuron differentiation in Notch-/- embryos (Hitoshi et al.
2002; Yoon and Gaiano 2005). This precocious neuron differentiation, however, leads to
fewer differentiated neurons due to the early depletion of the neural precursor pool in
these embryos (Hitoshi et al. 2002; Yoon et al. 2004). Active Notch signaling also
enhances and accelerates astrocyte differentiation (Gaiano and Fishell 2002; Grandbarbe
et al. 2003), and its overactivation promotes neural stem cell differentiation towards
oligodendrocyte precursor cells (OPC). However, this overactivation also inhibits OPC
differentiation to oligodendrocytes (Grandbarbe et al. 2003). NICD can interact with
players in both the Wnt and Hh signaling pathways. Thus, the impact of Notch on neural
differentiation likely goes beyond neural progenitor pool maintenance (Borggrefe et al.
2016).
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Figure 1-6: Notch Signaling
The Notch receptor binds the Delta ligand on an adjacent cell. Binding causes the
activation of the ADAM10 and -secretase proteases to activate and release the
intracellular domain of Notch (NICD), which translocates to the nucleus where it
interacts with transcription factors and co-transcriptional regulators to activate
transcription of target genes, like the Hes transcription factors. Image created with
Biorender.com.
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FGF signaling, described in Section 1.2, and shown in Figure 1-7, primarily functions to
maintain multipotent progenitors in the caudal stem zone during neurulation (Mathis et
al. 2001; del Corral et al. 2002), increase neural progenitor proliferation (McKinnon et al.
1990; Lin and Goldman 2009) and pattern the hindbrain (Sato and Nakamura 2004). FGF
signaling begins with the secretion of one of 22 ligands that activate tyrosine kinase
receptors (FGFR) on receiving cells (Zhang et al. 2006). As an RTK, FGFR activation
results in autophosphorylation and the recruitment of guanine nucleotide exchange factor
2 (GRB2), GRB2-associated binding protein 1 (GAB), son of sevenless and FGFR
substrate 2 (FRS2) (Teven et al. 2014). The recruitment of these proteins causes the
activation of two downstream pathways, the mitogen-activated protein kinase (MAPK)
and the phosphatidylinositol-3 kinase (PI3K)/AKT pathway (Yun et al. 2010). In the
MAPK pathway, Ras activation of MAPKKK (Raf) phosphorylates and activates
MAPKK (MEK), which in the cascade phosphorylates and activates MAPK (ERK) (Yun
et al. 2010; Teven et al. 2014). Effectors of the MAPK pathway include c-Jun N-terminal
kinase and p38 mitogen-activated kinase that through phosphorylation activate
transcription factors like c-Fos and c-Jun to promote the transcription of target genes
(Yun et al. 2010; Teven et al. 2014). Gene targets of MAPK signaling primarily include
cell proliferation related genes, although can also include genes involved in early neural
induction and neuron differentiation (Stock et al. 1992; Lamb and Harland 1995; Wilson
et al. 2000; Teven et al. 2014). The PI3K/AKT pathway is also activated by FGF, where
PI3K converts phosphatidylinositol-4,5-bisphosphate to phosphatidylinositol-3,4,5triphosphate that recruits and activates AKT (Yun et al. 2010; Teven et al. 2014), which
also have numerous effectors and biological responses. It remains unclear which pathway
is activated by FGF, but the presence of the secreted ligands and interfering with the
pathways regulated by them affect CNS development (Stock et al. 1992; Woodward et al.
1992). It is known that FGF signaling is required in cell proliferation and survival of
astrocyte precursors in the neonatal rat brain (Lin and Goldman 2009) and it increases
OPC proliferation while inhibiting their differentiation into oligodendrocytes (McKinnon
et al. 1990). FGF is also critical in posterior neural induction as a dominant negative
FGFR blocks the development of posterior neural tissue in Xenopus embryos (Ribisi et
al. 2000), but this may be due to its effects on pattern formation rather than neural
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differentiation (Holowacz and Sokol 1999). For example, Fgf8 is sufficient to convert the
diencephalon into the mesencephalon and to induce the presumptive mesencephalon to
pattern the cerebellum (Sato and Nakamura 2004). That said, FGF20 participates with
FGF2 to increase the differentiation of dopaminergic neurons (Takagi et al. 2005) and in
P19 cells, FGF overexpression promotes neuron differentiation (Chen et al. 2006). Other
in vitro work using human ESCs is more puzzling as it was reported that FGF must be
inhibited for neural differentiation to occur (Greber et al. 2011), while blocking MAPK
signaling abrogates neural differentiation (Cohen et al. 2010). Given the number of
receptor-ligand combinations and the multiple cellular signaling pathways activated in
response to FGF, the role of this signaling molecule during neural differentiation is not
clear. Although not explored in the present work, FGF signaling is recognized as being
essential in neural patterning and posterior neural cell fate.
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Figure 1-7: FGF Signaling
In the presence of fibroblast growth factor (FGF), the receptor tyrosine kinase is activated
and gets autophosphorylated prior to activating the MAPK or AKT pathways. In the
MAPK pathway (left), GRB2 and son of sevenless (SOS) convert inactive, GDP-bound
Ras to active, GTP-bound Ras. Active Ras stimulates Raf (MAPKKK), which in the
cascade phosphorylates MEK (MAPKK), required to activate MAPK (ERK), that
phosphorylates pathway effectors that enter the nucleus and activate transcription of cell
proliferation related genes. In the AKT pathway (right) the receptor causes the cascade to
activate AKT, which inhibits the TSC proteins leading to the activation of mTORC1.
This active mTORC1 complex can alter the expression of target genes that inhibit
autophagy and stimulate pro-survival. Image created using Biorender.com.
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Retinoic Acid (RA) signaling (Figure 1-8) is also involved in the development of
neuroectodermal lineages, specifically early neural specification, and forebrain
development (Maden 2007; Ghyselinck and Duester 2019). I used RA, paired with cell
aggregation to induce the differentiation of the P19 cells towards neuron and astrocyte
cell fates. Vitamin A, or retinol, is passively diffused into the cell where it is converted to
the active RA molecule. Retinol becomes retinaldehyde through retinol dehydrogenase
10 activity (RDH) (Metzler and Sandell 2016), and retinaldehyde becomes RA through
retinaldehyde dehydrogenase (RALDH) activity (Cunningham and Duester 2015). RA
can diffuse into the nucleus, where it is recognized by retinoic acid (RAR) and retinoid X
receptors (RXR) bound to the RA response element (RARE) sequences in the DNA
(Ghyselinck and Duester 2019). Binding affects transcription and the outcomes are
immense, and often unpredictable as there are up to 15,000 identified RAREs in the
mammalian genome (Moutier et al. 2012). Thus during embryogenesis, the number of
genes induced or repressed in response to active RA is not entirely clear, but it is well
known that RA is linked to neural induction and differentiation (Jones-Villeneuve et al.
1982; McBurney et al. 1988; Wichterle et al. 2002; Skromne et al. 2007; Chatzi et al.
2011; Sturgeon et al. 2011; Shin et al. 2012; Cunningham et al. 2015). RA has been used
in many in vitro models of neural differentiation, including but not limited to mESCs,
hESCs, embryonal carcinoma cells and neuroblastoma cells (Jones-Villeneuve et al.
1982; Sidell et al. 1983; Bain et al. 1996; Schuldiner et al. 2001; Wichterle et al. 2002;
Tonge and Andrews 2010). In P19 cells, an embryonal carcinoma line, RA has several
roles including the induction of FoxA1 expression during neural differentiation, which
activates Shh expression (Tan et al. 2010) and represses the pluripotency gene Nanog
(Chen et al. 2014). RA signaling in P19 cells has been well characterized (Edwards and
McBurney 1983; Wei et al. 1989; Pratt et al. 1990; Kruyt et al. 1992; Malý and Dráber
1992; Bain and Gottlieb 1994; Taneja et al. 1996), where varying concentrations give rise
to specific cell lineages and high concentrations (10-7 to 10-5 M) give rise to neural
phenotypes. Studies have also explored the expression patterns of RARs, RXRs and
cytosolic RA binding proteins throughout neural differentiation (Wei et al. 1989; Malý
and Dráber 1992; Bain and Gottlieb 1994; Taneja et al. 1996) and have established RA as
the key inducer of the neural phenotype (Pratt et al. 1990; Kruyt et al. 1992). In
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particular, the RAR types responsible for signaling in P19 cells are RAR and RAR
(Taneja et al. 1996), where dominant negative RAR inhibits neural differentiation
(Costa and McBurney 1996), as does the inhibition of RAR/RXR dimerization (Shago et
al. 1997). Cell aggregation and embryoid body formation, a key component of the in vitro
differentiation of P19 cells (Schmidt et al. 1992), regulates the expression patterns of the
RARs (Jonk et al. 1992); showing how 3D culturing and RA signaling in this model are
tightly linked. Not only is the positive propagation of RA signaling involved in P19
neural differentiation, but the negative regulation via RA hydroxylase and Cyp26 are also
required (Sonneveld et al. 1999). Given the involvement of RA in neural development in
P19 and other cell lines, my focus was on using it to better elucidate the Wnt and Hh
signaling regulators and the crosstalk that exists between these pathways.
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Figure 1-8: Retinoic Acid Signaling
Retinol in the extracellular space passively diffuses across the membrane where retinol
dehydrogenase (RDH) converts retinol to retinaldehyde. Retinaldehyde is converted to
retinoic acid (RA) by retinaldehyde dehydrogenase (RALDH), which diffuses into the
nucleus where it binds the RAR and RXR receptors. These receptors are bound to the
DNA at retinoic acid response elements (RAREs), which control the transcription of
genes. Binding can regulate the expression of up to 15,000 genes, including the FoxA1
transcription factor involved in neural differentiation. Image created using
Biorender.com.
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1.4

In vitro models of neural differentiation

Cells in culture have been used for decades to study the cellular mechanisms involved in
neural induction and differentiation. In vitro models of differentiation provide a costeffective approach to understanding the genes and protein signaling pathways governing
the complex processes of pluripotency, proliferation, induction, and differentiation. They
also corroborate what occurs in vivo and the utility of cultured embryonal carcinoma
cells, which are stem-like cells, have set the stage for numerous stem cell studies (Kelly
and Gatie 2017). For instance, the P19 embryonal carcinoma model has been used since
1982 to study neural differentiation (McBurney and Rogers 1982), but there are other
models that use similar differentiation cues to generate neurons and astrocytes. The P19
model, which I used in my study will be discussed in this section.

1.4.1

Embryonal carcinoma cell models of neural differentiation

Embryonal carcinoma models have been used extensively in the study of differentiation.
One of the first studies involved NTera2 (NT2) human embryonal carcinoma cells, which
readily differentiate to neurons in the presence of RA (Andrews 1984). Other carcinoma
cell lines include human SK-N-MC cells, rat PC12 cells, and mouse P19 cells, which
were selected for further study. P19 cells were derived from the subcutaneous
implantation of an E7.5 embryo in a mouse (McBurney and Rogers 1982), and reports
have shown that given the proper cues they differentiate into cardiac and skeletal muscle
or neural lineages (Jones-Villeneuve et al. 1982; Edwards and McBurney 1983;
McBurney 1993). P19 cells that differentiate in the presence of RA into neural lineages
require high density cell culturing and low serum conditions (Jones-Villeneuve et al.
1982; Edwards and McBurney 1983). These cells also produce astrocytes with RA
treatment and cell aggregation (Jones-Villeneuve et al. 1982; Spice et al. 2022b), while
protocols with monolayer cultures treated with RA in defined medium only produce
neurons (Monzo et al. 2012). More importantly, the neurons produced through embryoid
body (EB) formation and RA treatment are morphologically like primary neurons of the
rodent brain (McBurney et al. 1988). In addition, P19-derived neurons are similarly postmitotic (McBurney et al. 1988), form functional synapses (Morassutti et al. 1994) and
produce neurotransmitters, including those made by choline acetyltransferase, tyrosine
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hydroxylase, dopamine -hydroxylase and glutamic acid decarboxylase (JonesVilleneuve et al. 1983; Sharma and Notter 1988; Bain et al. 1993; Staines et al. 1994).
P19 cells also produce glutamate and differentiated neurons express glutamate receptors
(Ray and Gottlieb 1993) that are responsive when implanted into the adult rat brain
(Magnuson et al. 1995). It is interesting to note that these implanted neurons can survive
for over 30 days and points to the fundamental ability of these in vitro derived neurons to
integrate with the CNS of the host organism (Magnuson et al. 1995).
Other signaling pathways, like those previously described, regulate neural differentiation
in P19 cells. For instance, FGF signaling is involved in differentiation and is temporally
regulated by RA and dependent on EB formation (Chen et al. 2006; Alam et al. 2009).
MAPK and AKT are also essential in these cells as inhibition of AKT signaling (Mao and
Lee 2005; Fu et al. 2020), or inhibition of c-Jun N-terminal kinase, a downstream effector
of MAPK, reduces neuron differentiation (Wang et al. 2001). Notch signaling, another
pathway involved in neural differentiation has not been extensively explored in P19 cells,
but it is noteworthy that when these cells are cultured under hypoxic conditions, HIF1
interacts with NICD (Gustafsson et al. 2005), and Hes1 is rapidly upregulated during EB
formation (Wakabayashi et al. 2000). Most relevant to my investigation are the reports
showing P19 cells temporally regulating and utilizing canonical Wnt signaling to increase
neuron differentiation while inhibiting astrocyte formation (Smolich and Papkoff 1994;
Tang et al. 2002; Jing et al. 2009; Spice et al. 2022a). Finally, Hh signaling, also at the
centre of my study, plays a key role in neural differentiation of P19 cells as reports have
documented that RA induces Shh expression (Tan et al. 2010) and Gli2 overexpression is
sufficient to induce neurons (Voronova et al. 2011). Given the number of signaling
pathways reported to be involved in P19 neural differentiation, it is likely they are
playing various roles, individually and together, along the lineage commitment to
differentiation timeline. Cells undergoing differentiation must be competent to respond to
external signals before undergoing specification towards the neural lineage (Wilson and
Edlund 2001). Specified cells can then become committed towards a neuronal or glial cell
fate as distinct progenitors that can only give rise to their respective differentiated cell
types (Wilson and Edlund 2001). Temporal regulation of signaling pathways is thus key
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in defining these various identities throughout differentiation. It is interesting that the
involvement of Wnt and Hh signaling in P19 cells both play a role in neural
differentiation given the similarities and potential crosstalk that exists between the
regulators of these pathways. The P19 cell model was used to explore some of these
questions, specifically focusing on Sufu and Nek2. In the presented work I describe how
the P19 model differentiates in the presence of RA and various chemical signaling
modulators, as well as show changes in differentiation resulting from the genetic
manipulations of Sufu and Nek2. Finally, I should note that many researchers have
replaced embryonal carcinoma cells with embryonic stem cell lines, but I strongly believe
my work highlights the power of the P19 model to elucidate fundamental molecular
mechanisms related to neural differentiation.

1.5

Never in mitosis kinase 2 and development

The focus of this work was in exploring the role of Wnt and Hh signaling regulators in
neural differentiation. Although not usually thought of when discussing these pathways,
Never in mitosis kinase 2 (Nek2) has been recently identified as a regulator of both Hh
and Wnt pathways (Mbom et al. 2014; Cervenka et al. 2016; Wang et al. 2016; Zhou et
al. 2017). The primary role of Nek proteins is in regulating the cell cycle, where Nek2 is
known to regulate centrosome disjunction before mitosis (Fry 2002; Rellos et al. 2007;
Cervenka et al. 2016; Sahota et al. 2018). However, in Wnt signaling, Nek2 acts as a
positive regulator through -catenin and DVL (Mbom et al. 2014; Cervenka et al. 2016).
In Hek293T cells Nek2 phosphorylates -catenin, and blocks the interaction with -TrCP
to inhibit degradation (Mbom et al. 2014). This kinase also phosphorylates DVL,
increasing Wnt signaling responses in this same cell type (Cervenka et al. 2016). The
connection between Nek2 and Wnt signaling also occurs in colorectal cancer cells (Neal
et al. 2014), lung adenocarcinoma cells (Das et al. 2013), cervical cancer cells (Xu et al.
2020), breast cancer cells (Shen et al. 2019), and hepatocellular carcinoma cells (Lin et
al. 2016; Deng et al. 2019). In these cases, Nek2 overexpression caused increased catenin stabilization and target gene activity. In contrast to a role in Wnt signaling, Nek2
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acts as a negative regulator of Hh signaling (Wang et al. 2016; Zhou et al. 2017). Again,
in Hek293T cells, Nek2 binds, phosphorylates and stabilizes SUFU (Wang et al. 2016)
and is a Hh signaling target gene that acts in a negative feedback mechanism (Zhou et al.
2017). Although cancers are associated with overactive Hh signaling, no studies currently
exist linking Nek2 loss of function with Hh pathway activity in these cells. There are,
however, many studies showing overactivation of Nek2 is linked to malignancy and poor
patient survival (Yao et al. 2019), and to date many studies have reported this general
phenomenon (Liu et al. 2014, 2017; Boulay et al. 2017; Gu et al. 2017; Can et al. 2018;
Bai et al. 2021; Jian et al. 2021; Wan et al. 2021; Xing et al. 2021; Zhang et al. 2021;
Xiang et al. 2022).
Despite these studies highlighting the role of Nek2 in cancer, few studies have
investigated its role in embryonic development. We know Nek2 has been explored during
heart development where its knockdown in Xenopus causes left-right asymmetry and
looping defects (Joseph Endicott et al. 2015). These defects were not connected in this
work to Hh or Wnt signaling, rather instead to cilia dynamics (Joseph Endicott et al.
2015). However, since Hh signaling requires cilia (Briscoe and Thérond 2013), it is
possible that signaling was perturbed in these embryos and it was just not explored. Nek2
overexpression studies in Drosophila have linked Nek2 and Wnt signaling as
overexpression of Nek2 during eye development causes overactive wingless (Wnt)
signaling and reduces retinal neuron differentiation (Martins et al. 2017). To my
knowledge, there remains no study investigating the role of Nek2 in mammalian
neurogenesis. Since Nek2 expression has been observed in the brain of E10.5 mouse
embryos (Tanaka et al. 1997) and Nek3 is required for regulating microtubule dynamics
in mature neurons (Chang et al. 2009), Nek2 is very likely to have a role during
neurogenesis. Toward that end, I found that Nek2 plays an essential role in neuron and
astrocyte development, however, only Wnt signaling was suggested by the data to be
linked to Nek2 in the P19 model. Even more surprisingly, Nek2 was found to be
connected to hypoxia inducible factor 1 and mitochondrial electron transport chain
components to regulate metabolism during neural differentiation.
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1.6
1.6.1

Hypothesis, Study Aims & Key Findings
Hypothesis

Hh and Wnt signaling are key signaling pathways that regulate neural differentiation.
Although much is known about these pathways within this context, known and novel
pathway regulators have not been extensively studied within neural differentiation. To
address this, I used P19 embryonal carcinoma cells as a model to study the molecular
mechanisms orchestrating the transitions from pluripotency to neuron and astrocyte cell
fate. My objective was to explore the role of SUFU and Nek2 in neural differentiation,
where I had two hypotheses: 1) I hypothesized that if Hh signaling plays a role in neural
differentiation, then genetic ablation of the pathway regulator SUFU would block neural
differentiation through deregulation of Hh signaling, and 2) I hypothesized that if both
Hh and Wnt signaling play roles in neural differentiation, then genetic ablation of Nek2
would block differentiation through deregulation of both pathways.

1.6.2

Study Aims & Key Findings

Chapter 2
Study Aim: Determine the differentiation potential and evaluate changes to Hh signaling
within SUFU-deficient cells.
Key Finding: SUFU deficient cells increase expression of Hh target genes through the
complete loss of the Gli3 transcription factor, causing delayed and reduced astrocyte
formation without altering neuron differentiation.
Chapter 3
Study Aim: Determine the differentiation potential and evaluate changes to Hh and Wnt
signaling in cells overexpressing and lacking Nek2.
Key Finding: Nek2 promotes differentiation of neural precursor cells and is required for
the differentiation of neurons and astrocytes through its regulation of metabolism rather
than via Wnt or Hh regulation.
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Together my results support that Wnt and Hh signaling are key in P19 neural
differentiation and that SUFU plays a crucial role in Hh regulation. However, the role of
Nek2 in neural differentiation is not directly related to protein signaling pathway
regulation and instead is linked earlier to metabolic changes in these progenitor cells.

1.7
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Chapter 2

2

Suppressor of Fused regulation of Hedgehog Signaling
is Required for Proper Astrocyte Differentiation

Hedgehog signaling is essential for vertebrate development, however, less is known
about the negative regulators that influence this pathway. Using the mouse P19
embryonal carcinoma cell model, Suppressor of Fused (SUFU), a negative regulator of
the Hedgehog pathway, was investigated during retinoic acid-induced neural
differentiation. We found Hedgehog signaling increased activity in the early phase of
differentiation but was reduced during terminal differentiation of neurons and astrocytes.
This early increase in pathway activity was required for neural differentiation, however, it
alone was not sufficient to induce neural lineages. SUFU, which regulates signaling at the
level of Gli, remained relatively unchanged during differentiation, but its loss through
CRISPR-Cas9 gene editing resulted in ectopic expression of Hedgehog target genes.
Interestingly, these SUFU-deficient cells were unable to differentiate towards neural
lineages without retinoic acid, and when directed towards these lineages they showed
delayed and decreased astrocyte differentiation; neuron differentiation was unaffected.
Ectopic activation of Hh target genes in SUFU-deficient cells remained throughout
retinoic acid-induced differentiation and this was accompanied by the loss of Gli3,
despite the presence of the Gli3 message. Thus, the study indicates the proper timing and
proportion of astrocyte differentiation requires SUFU, likely acting through Gli3, to
reduce Hh signaling during late-stage differentiation.
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2.1 Introduction
Hedgehog (Hh) signaling plays pivotal roles in neural development, where Sonic
Hedgehog (SHH) is essential in patterning the differentiation of motor neurons and
interneurons in the neural tube (Wilson and Maden 2005) and inducing differentiation of
cerebellar neurons and glial cells (Dahmane and Ruiz 1999). When Hh ligand is absent,
the transmembrane receptor Patched (PTCH) inhibits the transmembrane protein
Smoothened (SMO) from translocating to the plasma membrane of the primary cilium
(Briscoe and Thérond 2013). Inhibition allows the Suppressor of Fused (SUFU) to
sequester full-length Gli transcription factors (Han et al. 2015) or promotes Gli
phosphorylation (Tempe et al. 2006) and partial proteosomal degradation into a truncated
repressor (Humke et al. 2010; Hui and Angers 2011). In the presence of Hh, however,
PTCH is inhibited, which allows the SUFU-Gli complex to be recruited into the primary
cilium (Haycraft et al. 2005). SUFU dissociates from Gli allowing the translocation of
Gli to the nucleus where it acts as a transcriptional activator (Humke et al. 2010). In
vertebrates there are three Gli proteins, with Gli1 serving solely as an activator as Gli1 is
a Hh target gene, present only after activation of the pathway (Hui and Angers 2011).
Gli2 and Gli3 are either transcriptional activators or repressors, with Gli3 acting
primarily as a repressor (Hui and Angers 2011). Thus, while Hh target gene transcription
is tightly regulated through Gli, other proteins regulate Glis. One of these is SUFU, a
regulator of Gli processing that is key to Hh pathway activation. Through the reduced
processing and stability of the Gli3 repressor (Makino et al. 2015), Sufu loss of function
alleles cause constitutive expression of Hh target genes in the absence of a Hh ligand
(Cooper et al. 2005; Svärd et al. 2006; Cwinn et al. 2011). Loss of Sufu in humans causes
medulloblastoma tumor growth (Taylor et al. 2002; Smith et al. 2018) and Nevoid Basal
Cell Carcinoma Syndrome (Urman et al. 2016; Smith et al. 2018), while mouse embryos
containing a targeted deletion of Sufu are embryonic lethal at E9.5 due to neural tube
closure defects (Cooper et al. 2005). Furthermore, the loss of Sufu function in the mouse
retina restricts retinal neuron differentiation (Cwinn et al. 2011) and in the cerebellum
results in developmental delays in neuron differentiation (Kim et al. 2018) and
cerebellum mispatterning (Kim et al. 2011).
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In the present study an in vitro system utilizing the mouse P19 embryonal carcinoma cell
line was employed to study when the Hedgehog pathway is activated, its requirement
during differentiation and the effects of Sufu loss of function on neural cell fate. The cell
line is readily differentiated into neural lineages in the presence of retinoic acid (RA)
(McBurney et al. 1982). RA causes P19 cells to develop functional neurons and
supporting astrocytes (McBurney et al. 1988), and although this is well-known, few
studies have investigated the role of Hh signaling in this system (Voronova et al. 2011;
Lin et al. 2012). Of these, one study showed the overexpression of a constitutively active
Gli2 promotes neuronal differentiation (Voronova et al. 2011), but another revealed the
knockdown of Gli2 causes the same phenotype (Lin et al. 2012). Thus, these and many
unanswered questions remain, and though Hh signaling is precisely controlled in vivo,
how SUFU is involved in determining neuron and astrocyte cell fate decisions is not
known. To address this shortfall, this study aims to better understand the essential role of
SUFU in neuroectodermal differentiation. Using the P19 cell model and timeline
investigations, we show when Hh signaling is required during RA-induced neural
differentiation, and through genetic ablation of Sufu, demonstrate that there is an
essential role for SUFU in astrocyte determination.

77

2.2
2.2.1

Materials and Methods
Cell culture & Differentiation

P19 embryonal carcinoma cells (a gift from Dr. Lisa Hoffman, Lawson Health Research
Institute, London, ON) and Sufu knockout (Sufu-/-, described below) P19 cells were
cultured on adherent tissue culture plates in DMEM containing 5% fetal bovine serum
and 1% pen/strep at 37°C and 5% CO2. Cells were passaged every 4 days or at 70%
confluency, whichever occurred first. To induce neural differentiation, approximately
1.05x106 cells were cultured on bacterial grade Petri dishes for 4 days in 0.5 μM RA to
form embryoid bodies (EB) (McBurney et al. 1988). Next, EBs were resuspended and
plated on adherent tissue culture dishes in the presence of 0.5 μM RA, for a total of 10,
14 or 17 days. Untreated controls were grown as described, but without RA. For
Smoothened Agonist (SAG; EMD Millipore) and Cyclopamine (Cyc; EMD Millipore)
studies, cells were cultured as above but in the presence of 0.5 μM RA plus 10 nM SAG
or 10 μM Cyc, or 10 nM SAG alone during EB formation; then replated as described
above in the presence of 0.5 μM RA or were left untreated for the SAG-only treatment.

2.2.2

Cas9 plasmid preparation

The pSpCas9(BB)-2A-Puro (PX459) V2.0 (Addgene plasmid: 62988) was used, where
sgRNAs for Sufu (Supplementary Table 1) were cloned into the PX459 vector (Ran et al.
2013). Briefly, sgRNAs were amplified and phosphorylated, the vector digested using the
BbsI restriction enzyme, and vector and sgRNA were incubated at room temperature for
1.5 h for ligation. Ligated plasmids were transformed into competent bacteria, colonies
were selected, and isolated plasmids were sequenced at the London Regional Genomics
Centre (Robarts Research Institute, London, ON) using the U6 primer (Supplementary
Table 1).

2.2.3

Knockout lines

PX459-sgRNA plasmid (2 g) was transfected using 10 L of Lipofectamine 2000
(Invitrogen). After 4 h, media was changed, and cells were grown to 70% confluency for
clonal selection. Selection media containing 1 g/mL puromycin was replaced every 24 h
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for 4 days, and then cells were grown in complete media without puromycin until ready
to be passaged. Knockout genotypes were determined by collecting genomic DNA
(Qiagen DNeasy® Blood & Tissue kit, 69504), and performing standard PCR
(DreamTaq Master Mix (2X), Thermo Scientific) with Sufu-specific primers (Table 2-1).
Amplicons were sequenced at the London Regional Genomics Centre and compared to
wildtype sequences using pair-wise sequence alignment (Geneious 2021™). KO line #2
sequencing was examined using TIDE analysis (http://shinyapps.datacurators.nl/tide/)
(Brinkman et al. 2014) to further investigate the nature of the allele. TIDE analysis was
unable to interrogate KO line #1 as the length of deletion was outside of the tool
parameters.
Table 2-1: gRNA and primer sequences for CRISPR-Cas9 editing of Sufu gene
Sufu gRNA

CRISPR-Cas9
GGCTGATAACTGACATGCGG

Sufu gRNA
Sufu PCR
U6

Forward Primer (5’ → 3’)
CACCGGGCTGATAACTGACATGCGG
CTCCATCCCACCTGTAGAGTTC
GGGCAGGAAGAGGGCCTAT

2.2.4

Reverse Primer (5’ → 3’)
AAACCCGCATGTCAGTTATCAGCCC
AGCAAGGTTTTCCTCACTCAAG

Overexpression lines

Sufu KO #2 was transfected with 2 g of either 1436 pcDNA3 Flag HA (Addgene
plasmid: 10792), a pcDNA Flag HA vector with the Sufu open reading frame cloned from
pcDNA Su(fu) (CT #116) (Addgene plasmid: 13857) (Pearse et al. 1999) using BamHI
(New England Biolabs) and XhoI (New England Biolabs) restriction enzymes, or hGli3
flag3x (Addgene plasmid: 84921) using Lipofecatime 2000 (Invitrogen). Cells were
incubated for 4 hours in the presence of plasmid, media was then changed, and cells were
grown to 70% confluency. Transfected cells were treated with 500 g/mL neomycin
(G418) selection media every 48 hours for 2 weeks.

2.2.5

Real-time reverse transcriptase PCR

To determine relative mRNA expression levels total RNA was collected from RA-treated
cells at various time points using QiaShredder (Qiagen) and RNeasy (Qiagen) kits. cDNA

79

was made using a High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher
Scientific) and amplification was performed using gene-specific primers (Table 2-2). RTqPCR was done using 500 nM of each reverse and forward primers, 10 μL of SensiFAST
SYBR No-ROX Mix (Bioline), and 1 μL of cDNA template. Samples were analyzed
using a CFX Connect Real-Time PCR Detection System (Bio-Rad) using the
comparative cycle threshold method (2-ΔΔCt). Relative expression was normalized to L14
and untreated or wildtype untreated controls to determine fold change expression.
Table 2-2: RT-qPCR Primers List
Gene
L14
Shh
Ihh
Dhh
Smo
Ptch1
Ptch2
Sufu
Gli1
Gli2
Gli3
Ascl1
NeuroD1
NeuroG1
GFAP
S100b
Aldh1l1
Chicken
Sufu

2.2.6

qRT-PCR
Forward Primer (5’ → 3’)
GGGTGGCCTACATTTCCTTCG
AAAGCTGACCCCTTTAGCCTA
GACTCATTGCCTCCCAGAACTG
ACCCCGACATAATCTTCAAGGAT
CCTGACTTTCTGCGTTGC
AAAGAACTGCGGCAAGTTTTTG
CTCCGCACCTCATATCCTAGC
CGGACCCCTTGGACTATGTTA
GGAAGTCCTATTCACGCCTTGA
TACCTCAACCCTGTGGATGC
CTGTCGGCTTAGGATCTGTTG
ACTTGAACTCTATGGCGGGTT
GCATGCACGGGCTGAACGC
CCAGCGACACTGAGTCCTG
CCAAGCCAAACACGAAGCTAA
TGGTTGCCCTCATTGATGTCT
CATCCAGACCTTCCGATACTTC
ACGGGCAAGGAATCTTGGAG

Reverse Primer (5’ → 3’)
GAGTACAGGGTCCATCCACTAAA
TTCGGAGTTTCTTGTGATCTTCC
CCAGGTAGTAGGGTCACATTGC
GTACTCCGGGCCACATGTTC
GGTTCTGACACTGAATCCG
CTTCTCCTATCTTCTGACGGGT
TCCCAGGAAGAGCACTTTGC
CTTCAGACGAAACGTCAACTCA
CAACCTTCTTGCTCACACATGTAAG
CTACCAGCGAGTTGGGAGAG
GCTCTTCAGCAAGTGGTTCC
CCAGTTGGTAAAGTCCAGCAG
GGGATGCACCGGGAAGGAAG
CGGGCCATAGGTGAAGTCTT
CATTTGCCGCTCTAGGGACTC
CTCGTTGTTGATAAGCTCCTTCAG
ACAATACCACAGACCCCAAC
ACTCTCTCTTGCAGATGCGG

Immunoblot Analysis

Cells were lysed in 2% SDS buffer containing 62.5 mM Tris-HCL pH 6.8, 10% glycerol,
5% mercapto-2-ethanol and 1X Halt Protease Inhibitor Cocktail (Thermo Scientific;
1:200). Proteins were separated using SDS-PAGE, then transferred to PVDF membranes
(Bio-Rad, 1620177). Membranes were probed with primary antibodies to β-III-tubulin
(1:1000; Cell Signaling Technology), GLI3 (1:1000; R&D Systems), SUFU (1:1000;
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abcam), GFAP (1:1000; Invitrogen) and β-actin (1:10,000; Santa Cruz Biotechnology)
and then with the appropriate HRP-conjugated secondary antibodies (1:10,000, Sigma).
Signals were detected using the Immobilon® Classico Western HRP Substrate
(Millipore) and imaged using a Chemi Doc Touch System (Bio-Rad).

2.2.7

Immunofluorescence

Cells were differentiated, as stated previously, on coverslips coated with poly-L-lysine
hydrobromide (Sigma), fixed with 4% paraformaldehyde for 10 min and permeabilized in
0.2% Triton-X-100 for 10 min at room temperature. Coverslips were incubated for 30
min in 1% Bovine Serum Albumin, 22.52 mg/mL glycine and 0.1% Tween-20, then
overnight in a humidity chamber with β-III-tubulin (TUJ1, 1:400; Cell Signaling
Technology) and GFAP (1:500; Invitrogen). Incubation in secondary antibodies (1:400),
Alexa Fluor™ 660 goat anti-mouse IgG (Invitrogen) and Goat anti-Rabbit IgG Alexa
Fluor Plus 488 (Invitrogen) was done in the dark for 1 h at room temperature. Coverslips
were mounted onto microscope slides using Slowfade™ Gold antifade reagent with
DAPI (Invitrogen) and cells were examined using a Zeiss AxioImager Z1 Compound
Fluorescence Microscope at the Integrated Microscopy Facility, Biotron (Western
University, London, ON). Images were analyzed using ImageJ.

2.2.8

Flow Cytometry

Cells, differentiated as stated previously, were washed with ice cold PBS without
magnesium or chloride (PBS(-/-)) (Thermo Fisher) and dissociated with 0.25% Trypsin.
Trypsin was deactivated with DMEM/F12 (Thermo Fisher) containing 10% ES-grade
FBS (Thermo Fisher), and cells were centrifuged at 300 g for 5 minutes and reconstituted
in PBS(-/-). Cells were counted using a trypan blue assay, separated to approximately
1.0x106 cells per tube, and washed in Flow Cytometry Staining Buffer (10% FBS in
PBS(-/-)). Cells were fixed using 4% formaldehyde in PBS(-/-) for 10 min at room
temperature, washed with ice cold PBS(-/-) and permeabilized with 0.2% Triton-X-100 in
PBS(-/-) for 10 min. Cells were incubated with or without 1 L of GFAP Monoclonal
Antibody (GA5), Alexa Fluor 488, eBioscience™ (Invitrogen) per million cells for 1 h at
room temperature, and then washed with PBS (-/-), strained using a 40 m strainer
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(Falcon™) and analyzed using a BD FACSCanto II flow cytometer at the London
Regional Flow Cytometry Facility (Robarts Research Institute). Data were analyzed
using FlowJo (BD). Flow cytometry gating strategy is reported in Figure 2-1.
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Figure 2-1: Flow cytometry gating strategy of P19 cells
Flow cytometric gating scheme of P19 wild type (A) and knock out (B) cells. Wild type
P19 cell doublets were removed by gating for a second population (P1) examining
forward scatter – height versus forward scatter – area. Cells of interest were selected by
gating for side scatter – area versus forward scatter – area in a secondary population (P2).
Live cells were distinguished from dead cells by gating through a comparison of a
live/dead Zombie AquaTM stain (405) versus forward scatter –area. The final gating
threshold isolates cells positive for GFAP staining (488).
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2.3
2.3.1

Results
Retinoic acid and cell aggregation induces P19 neural
differentiation

To induce neural differentiation cells were treated for 4 days in 0.5 M RA to form EB,
which were then plated for a total of 10 days to form neurons or 17 days to form
astrocytes (Figure 2-2A). Differentiation was confirmed with RT-qPCR of NeuroD1,
NeuroG1 and Ascl1 increasing and subsequently decreasing expression (Figure 2-2B). As
expected (Jones-Villeneuve et al. 1982), the neuronal marker, -III-tubulin was detected
following RA treatment at 10 days (Figure 2-2C) and coinciding with prominent signals
for Glial Fibrillary Acid Protein (GFAP), an astrocyte marker, that increased by day 17
(Figure 2-2C). Neither marker was prominent in cells undergoing spontaneous
differentiation in the absence of RA (Figure 2-2C), and together confirmed that neurons
and astrocytes differentiated by RA.
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Figure 2-2: Retinoic acid is required for P19 cell neural differentiation
(A) Schematic of in vitro differentiation of P19 cells toward neural lineages. (B) RTqPCR of NeuroG1, NeuroD1, and Ascl1 expression on days 0-17 of RA-induced
differentiation. (C) Immunoblot of -III-tubulin and GFAP on days 0-17 of RA-induced
differentiation. N=3. Bars represent mean values  s.e.m. Panel A was created using
BioRender.com.
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2.3.2

Hh signaling is activated early in neural differentiation

Since reports note that Shh signaling is vital in vertebrate neural differentiation
(Dahmane and Ruiz 1999; Wilson and Maden 2005; Briscoe and Thérond 2013), RTqPCR was used to explore Hh component expression throughout RA treatment of P19
cells. Hh ligands Dhh, Ihh, and Shh were significantly upregulated after 1 day of RA
treatment (P<0.001, 0.01 and 0.05, respectively), as was Gli1 (P<0.001), a Hh target
gene, before returning to basal levels (Figure 2-3A). Expression of Ptch1, Ptch2, Smo,
Gli2, Gli3 and Sufu (Figure 2-3A) were also confirmed. Since Gli3 can serve as an
activator or repressor (Hui and Angers 2011), Gli3 levels were explored throughout RA
induced differentiation. Full-length Gli3 (Gli3FL) was significantly increased 1 day after
RA treatment (Figure 2-3B and C), whereas Gli3 repressor (Gli3R) was increased at days
2, 4 and 6 of RA treatment. As the activation of Hh signaling is dependent on the ratio
between Gli3FL and Gli3R, this ratio was examined, and results showed an increase in
the Gli3FL to Gli3R ratio 1 day after RA treatment (Figure 2-3C). Given these data, it
would appear that Hh pathway activity is increased early in neural differentiation of P19
cells, where it subsequently returns to basal levels coinciding with neuron and astrocyte
differentiation.
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Figure 2-3: Hh signaling is activated early in RA-induced differentiation
(A) RT-qPCR showing expression of Hh ligands Dhh, Ihh, Shh, receptors Ptch1 and
Ptch2, intermediate pathway components Smo and Sufu, Hh target gene and transcription
factors Gli1, Gli2 and Gli3 on days 0-17 of RA-induced differentiation. (B) Immunoblot
of Gli3 full length (Gli3FL) and Gli3 repressor (Gli3R) on days 0-17 of RA treatment.
(C) Densitometric analysis of Gli3FL, Gli3R and the Gli3FL to Gli3R ratio of
immunoblot in B. N=3. Bars represent mean values  s.e.m. P-values were determined by
One-way ANOVA with Tukey’s post-hoc analysis, *P<0.05, **P<0.01, ***P<0.001,
****P<0.0001.
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2.3.3

Early Hh signaling is required but not sufficient for neural
differentiation

To first address if activation of Hh signaling would affect differentiation, cells were
treated with 0.5 μM RA (RA), 0.5 μM RA plus 10 nM SAG on day zero (RA + SAG d0),
10 nM SAG alone on day zero (SAG d0) or 10 nM SAG on day 0 with subsequent 0.5
μM RA treatment on day 4 (SAG d0 + RA d4). Immunoblots showed -III-tubulin in
RA, RA + SAG d0 and SAG d0 + RA d4 treatments but not in SAG d0 treatment alone
on day 10 (Figure 2-4A). Densitometric analysis revealed an increase in -III-tubulin
intensity in the RA + SAG d0 treatment compared to RA alone, but no difference
between RA alone and the SAG d0 + RA d4 treatment (Figure 2-4B). Experiments
allowing cell aggregation for 4 days in the absence of RA, then subsequent 0.5 μM RA
treatment at day 4 (DMSO d0 + RA d4), also showed the -III-tubulin signal at day 10,
as did cells in the presence of DMSO only (DMSO d0 + DMSO d4); however, both
treatments were significantly less than the RA treatment alone (Figure 2-5A and B).
Therefore, SAG over-activation of Hh signaling, in the presence of RA, appeared to
enhance the neuron cell fate while SAG alone was not sufficient to induce neurons.
Immunoblot analysis of GFAP showed detection on day 17 in the RA and RA + SAG d0
treatments, but no signals were seen in the SAG d0 alone treatment (Figure 2-4A).
Furthermore, densitometric analysis showed increased GFAP intensity in the RA + SAG
d0 treatment compared to RA treatment alone (Figure 2-4C). A GFAP band was also
seen in the SAG d0 + RA d4 treatment (Figure 2-4A), but densitometric analysis revealed
that this signal was not significantly different from the SAG d0 alone treatment (Figure 24C). DMSO d0 + RA d4 cells also showed this low level of GFAP at day 17 (Figure 25A), indicating that RA treatment at this later time was sufficient to induce astrocytes;
however, not to the extent observed with the initial RA treatment. As the changes to
neural cell fates in the presence of SAG were subtle, we confirmed SAG activation of Hh
was occurring in these cells through a luciferase assay (Figure 2-5D). Thus, it appears
from immunoblot data that supplementing the initial RA treatment with SAG increases
astrocyte differentiation, but activation of Hh signaling alone using SAG was not
sufficient to induce the astrocyte fate.
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Since early Hh pathway activation enhances neural cell fates, would its attenuation affect
neural differentiation? Cells were treated with either 0.5 μM RA (RA) or 0.5 μM RA plus
10 μM Cyc on day 0 (RA + Cyc d0); both with subsequent RA treatments on day 4.
Immunoblot analysis of -III-tubulin on day 10 showed signals in both RA and RA +
Cyc treatments (Figure 2-4D), but densitometry revealed the intensity was significantly
reduced with Cyc treatment (Figure 2-4E). Cyc also had dramatic effects on GFAP
levels, eliminating the response induced by RA (Figure 2-4D and F). Experiments with
cells treated with RA plus the Cyc vehicle (RA + DMSO d0) showed no significant
change in either marker (Figure 2-5C). These results suggest that inhibition of the Hh
pathway attenuates neuron and astrocyte cell fates, and thus is required for proper
differentiation of these cell types.
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Figure 2-4: Early Hh pathway activation is required but not sufficient to induce
neural lineages
(A) Immunoblot of -III-tubulin and GFAP on days 10 and 17 of cells treated with RA
alone, RA plus SAG on day 0 (RA + SAG d0), SAG alone on day 0 (SAG d0) or SAG on
day 0 plus RA on day 4 (SAG d0 + RA d4) treatment. (B) Densitometry of -III-tubulin
and (C) of GFAP from immunoblot in A. (D) Immunoblot of -III-tubulin and GFAP on
days 10 and 17 of cells treated with RA or RA plus Cyclopamine (Cyc) (RA + Cyc d0)
on day 0. (E) Densitometry of -III-tubulin and (F) GFAP from immunoblot in D. N=3.
Bars represent mean values  s.e.m. P-values were determined by Two-way ANOVA
with Sidak’s post-hoc analysis, *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.
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Figure 2-5: DMSO alone and DMSO plus RA treatment is sufficient to induce
neurons but not astrocytes
Immunoblots and densitometry analyses of β-III-tubulin and GFAP in cells treated with
RA or (A) DMSO on day 0 and 0.5 uM RA on day 4 (DMSO d0 + RA d4), (B) DMSO
treatments on days 0 and 4 (DMSO d0 + DMSO d4) and (C) RA plus DMSO on day 0
(RA + DMSO d0). (D) Luciferase assay of Gli responsive reporter in DMSO and SAG
treated undifferentiated cells. N=3. Bars represent mean values  s.e.m. P-values were
determined by Two-way ANOVA with Sidak’s post-hoc analysis. *P<0.05, ***P<0.001,
****P<0.0001.
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2.3.4

SUFU levels during neural differentiation

SUFU negatively regulates Gli activity and as reported by Humke et al. (Humke et al.
2010), promotes Gli3 conversion to a repressor. To determine its role in Hh signaling
seen in P19 cells, Sufu gene expression was examined and found to be moderately
increased on day 1, 8 and 10 of RA treatment (Figure 2-3A); however, at the protein level
no changes were seen across any timepoints of RA treatment (Figure 2-6). Since Sufu
expression and protein levels remain largely unchanged it is tempting to speculate that
the early activation of the Hh pathway is controlled by the cellular localization or posttranslational modification status of SUFU.
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Figure 2-6: SUFU levels do not change during RA-induced neural differentiation
Immunoblot of SUFU at select times during RA treatment and corresponding
densitometry. N=3. Bars represent mean values  s.e.m. P-values were determined by
One-way ANOVA with Tukey’s post-hoc analysis.
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2.3.5

Sufu knockout activates Hedgehog signaling

Since SUFU acts as an essential regulator of Gli3 (Humke et al. 2010) and Gli2 (Humke
et al. 2010; Han et al. 2015), its loss was expected to induce Hh signaling. To test this,
CRISPR-Cas9 was used to target exon 6 of the Sufu gene (Figure 2-7A), resulting in
clones with an 81 bp deletion (KO #1) that spans the intron-exon boundary between
intron 5 and exon 6 and another with a 1 bp insertion (KO #2). Sequence alignment,
TIDE analysis (Brinkman et al. 2014) and in silico translation of clones revealed a
premature stop codon shortly after the mutation (Figure 2-8). Immunoblot analyses using
a SUFU antibody targeted to the C-terminus of SUFU, a region reported to be required
for GLI binding (Dunaeva et al. 2003; Han et al. 2015), was detected in untreated WT
cells, but was not in either mutant clone (Figure 2-7B). SUFU levels were also unchanged
in Cas9 vector transfected cells without SUFU-specific gRNA (labeled PX459), in
addition to vector transfected cells showing no change in differentiation marker
abundance compared to WT cells (Figure 2-9). To determine other effects, Sufu-/- alleles
caused a decrease in cell numbers compared to WT cells cultured to 96 h (Figure 2-7C);
however, MTT analysis at the same time points showed no change in MTT absorbance
(Figure 2-7D). As predicted, KOs showed increased expression of Hh targets Gli1, Ptch1,
and Ascl1 in undifferentiated cultures (Figure 2-7E). Thus, the data shows the loss of
SUFU does not greatly affect the proliferation of undifferentiated cells, contrary to that
reported in mouse neural stem cells of the dentate gyrus (Noguchi et al. 2019), and
instead it induced Hh target gene expression in P19 cells.
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Figure 2-7: CRISPR-Cas9 knock out of Sufu activates Hh signaling in
undifferentiated P19 cells
(A) Schematic showing gRNA targeting exon 6 of the Sufu gene yielding two KO clones.
(B) Immunoblot of SUFU levels in wildtype (WT) and Sufu-/- clones. (C) Cell count
curves of WT and Sufu-/- clones between 0-96 hours and (D) MTT assay of the difference
in absorbance of MTT reagent in WT and KO cells at 560nm and 750nm. (E) Expression
of Gli1, Ptch1 and Ascl1 in WT and Sufu-/- clones in undifferentiated cultures. N=3. Bars
represent mean values  s.e.m. P-values for C and D were determined by Two-way
ANOVA with Sidak’s post-hoc analysis and for E were determined by One-way ANOVA
with Tukey’s post-hoc analysis. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.
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Figure 2-8: TIDE analysis of Sufu-/- clone (KO#2)
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(A) Indel spectrum analysis showing predicted mutant allele after sequence alignment.
Bars represent percent of sequences identified during analysis, with red bars being
statistically significant. (B) Aberrant sequence analysis after sequence alignment. Black
lines represent wildtype sequence and green lines represent alignment of mutant
sequence. Dashed line represents the predicted cut site. Taller green compared to black
lines indicate a likely mutation. (C) Inserted nucleotide probability score after Indel
spectrum analysis.
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Figure 2-9: CRISPR-Cas9 plasmid transfection and selection do not affect SUFU
levels or P19 cell differentiation
Immunoblots and corresponding densitometry of (A) SUFU and (B) differentiation
markers -III-tubulin and GFAP. N=3. Bars represent mean values  s.e.m. P-values of
SUFU levels were determined by One-way ANOVA with Tukey’s post-hoc analysis.
Differentiation marker P-values were determined by Two-way ANOVA with Sidak’s
post-hoc analysis. ***P<0.001, ****P<0.0001.
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2.3.6

Sufu loss activates Hh signaling through loss of Gli3

RT-qPCR was used to determine if the observed activation of Hh signaling in the KO
lines was maintained throughout RA-induced differentiation. Sufu-/- cells treated with RA
maintained higher Gli1 (Figure 2-10A and Figure 2-11A) and Ptch1 (Figure 2-10B and
Figure 2-11B) expression compared to that in WT cells. Since previous work also showed
the connection between SUFU and Gli3 processing (Humke et al. 2010), and we were
particularly interested in Gli3 expression and protein levels. Results show no significant
differences in Gli3 expression between Sufu-/- and WT cells in KO#2 (Figure 2-10C),
however, significantly decreased Gli3 levels were observed at days 10, 14 and 17 in KO
#1 (Figure 2-11C). At the protein level, neither the Gli3 repressor nor full-length Gli3
were detected in KO #2 (Figure 2-10D), and this was consistent with KO #1 having
decreased or absent Gli3 levels (Figure 2-11D). Thus, the loss of SUFU, specifically the
region of the polypeptide required for Gli3 processing, likely contributes to posttranslational perturbations to Gli3, causing its loss and the observed higher expression of
Hh target genes.
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Figure 2-10: Sufu-/- #2 maintains increased Hh signaling and causes the loss of Gli3
Expression of (A) Gli1 and (B) Ptch1 and (C) Gli3 in wildtype (WT) and Sufu-/- KO #2
cells on days 0-17. (D) Immunoblot of Gli3 full length (Gli3FL) and Gli3 repressor
(Gli3R) in WT and Sufu-/- KO #2 cells on days 0-17. N=3. Bars represent mean values 
s.e.m. P-values were determined by Two-way ANOVA with Sidak’s post-hoc analysis.
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.
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Figure 2-11: Sufu-/- #1 maintains increased Hh signaling and causes the loss of Gli3
Expression of (A) Gli1 (B) Ptch1 and (C) Gli3 in wildtype (WT) and Sufu-/- KO #1 cells
on days 0-17. (D) Immunoblot of Gli3 full-legnth (Gli3FL) and Gli3 repressor (Gli3R) in
WT and Sufu-/- KO #1 cells on days 0-17. N=3. Bars represent mean values  s.e.m. Pvalues were determined by Two-way ANOVA with Sidak’s post-hoc analysis. *P<0.05,
***P<0.001, ****P<0.0001.
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2.3.7

Sufu knockout delays and decreases the astrocyte cell fate

If the Sufu knockout induced Hh target genes what effect would this have on neural
differentiation? To determine if KO cells could differentiate in the absence of RA, these
cells were aggregated and replated in the absence or presence of RA. Both KO lines
treated with RA showed -III-tubulin signals at day 10 and GFAP signals on days 14 and
17; neither marker was detected in the absence of RA (Figure 2-12A). To determine if the
timing or degree of differentiation was affected by the loss of SUFU, the expression of
these markers was compared in each knockout line with that in WT cells at days 10, 14
and 17 in the presence of RA (Figure 2-12B). Densitometric analyses confirmed -IIItubulin levels did not change between WT and KO cells (Figure 2-12C). Significantly,
astrocyte differentiation was affected and GFAP signals on immunoblots were absent on
day 10 and reduced on day 14 of RA treatment in Sufu-/- cells compared to WT (Figure 212B and D). The absence of GFAP on day 10 was interpreted cautiously, as in WT cells,
we have seen inconsistencies in GFAP levels at this time point. Nevertheless, GFAP
levels are consistently high in WT cells at day 14 (Figure 2-2C and Figure 2-15A) and it
appeared removing SUFU delayed astrocyte differentiation when RA was present. To
further confirm this result, RT-qPCR was used to measure expression of astrocyte
markers GFAP, aldehyde dehydrogenase 1 family member L1 (Aldh1l1) and S100
calcium-binding protein B (S100b) (Figures 2-12, E-G, respectively). Consistent with
immunoblotting results, GFAP expression was reduced on days 10 and 14, and unlike the
immunoblotting was also reduced at day 17 of RA treatment (Fig. 2-12E). Aldh1l1
expression, like GFAP, was also reduced in KO cells compared to WT at days 10, 14 and
17 of RA treatment (Fig. 2-12F). Interestingly, S100b expression was reduced at day 10
of RA treatment in KO compared to WT cells, however, it was not different from WT at
day 14 and was increased compared to WT at day 17 (Fig. 2-12G).
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Figure 2-12: Sufu-/- delays astrocyte formation without affecting neuron
differentiation
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(A) Immunoblot of -III-tubulin and GFAP on days 0-17 in Sufu-/- KO clones. (B)
Immunoblots of -III-tubulin and GFAP on day 10, day 14 and day 17 in wildtype (WT)
and Sufu-/- clones, and densitometric analyses of immunoblots of B) showing relative
intensities of (C) -III-tubulin and (D) GFAP. P-values were determined by One-way
ANOVA with Tukey’s post-hoc analysis. RT-qPCR of astrocyte markers (E) GFAP, (F)
Aldh1l1, and (G) S100b. P-values were determined by Two-way ANOVA with Sidak’s
post-hoc analysis. N=3. Bars represent mean values  s.e.m. *P<0.05, **P<0.01.
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To resolve the discrepancy between immunoblotting and RT-qPCR results of GFAP,
immunofluorescence analysis with antibodies to -III-tubulin and GFAP were used on
WT and Sufu-/- cells. Given the immunoblotting results (Fig. 2-12B and D), we were
expecting to see no differences in either marker between the two cell lines at day 17 of
RA treatment. However, this analysis revealed a reduction in GFAP-positive staining in
Sufu-/- cells (Figure 2-13A, quantified in B). This observed reduction also occurred
despite the KO cells having increased cell viability (Fig. 2-13C) and increased total cells
(Fig. 2-13D) as measured by trypan blue exclusion assay at both days 10 and 17 of RA
treatment. However, since these cells are highly heterogenous and exist in areas of highdensity, flow cytometry was used, and results confirmed this reduction showing Sufu-/cells (6-25%) had significantly less GFAP-positive staining compared to WT cells (6070%; Figure 2-13E and F). It should also be noted that although the immunoblot data at
day 17 was inconsistent with the immunofluorescence and flow analysis, the flow
cytometry had identified high GFAP levels (Figure 2-13E) in some Sufu-/- cells, even
though overall there were fewer GFAP positive cells present in the KO line (Figure 213E). Nevertheless, these data support the idea that the loss of Sufu does not alter
neuronal differentiation, but it does delay and decrease astrocyte differentiation.
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Figure 2-13: Sufu-/- decreases astrocyte differentiation
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(A) GFAP (red) and -III-tubulin (green) fluorescence and nuclear DAPI (blue) staining
in wildtype (WT) and Sufu-/- KO clone #2 cells on day 17 of RA treatment. Scale bar =
200 m. (B) Quantification of positive cells from images in A. P-values were determined
by Student’s t-test. Trypan blue exclusion measuring (C) % cell viability and (D) total
cell number at days 10 and 17 in WT and KO #2. P-values were determined by Two-way
ANOVA with Sidak’s post-hoc analysis. (E) Flow cytometry of GFAP-positive WT and
Sufu-/- KO #2 cells on day 17 and quantified in F. P-values were determined by Student’s
t-test. N=3. Bars represent mean values  s.e.m. *P<0.05, **P<0.01, ***P<0.001,
****P<0.0001.
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2.3.8

Sufu or Gli3 overexpression partially rescues astrocyte
phenotype

If the loss of Sufu resulted in delayed and decreased astrocyte differentiation (Figure 2-12
and Figure 2-13) and this was likely due to the loss of Gli3 (Figure 2-10D and Figure 211D), then overexpression of a CRISPR-insensitive chicken Sufu (pSUFU) or human
GLI3 (pGli3) in Sufu knockout cells should rescue the phenotype and astrocyte levels
should increase in these mouse cells. Overexpression was confirmed by RT-qPCR of
chicken Sufu and immunoblotting of human Gli3 (Figure 2-14). To determine the effect
this overexpression had on astrocyte differentiation, GFAP levels were explored
following pSUFU or pGli3 stable transfection in knockout cells. Results showed no
GFAP detection on day 10, but there was an increase by day 14 of RA treatment, albeit
not to the levels observed in the WT cells (Figure 2-15A and B). GFAP levels were
maintained at day 17 in the human pGli3 stably transfected cells, but chicken pSUFU
stably transfected cells showed significantly reduced levels compared to the WT or other
transfected Sufu-/- cells (Figure 2-15A and B). Despite these minor differences, these
results show that chicken Sufu and human GLI3 overexpression partially rescue astrocyte
differentiation and highlights not only the essential role of Gli3 in neural differentiation,
but a major role for SUFU in regulating Gli3.
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Figure 2-14: pSUFU and pGli3 overexpression induces Chicken Sufu expression and
rescued detection of Gli3
(A) Chicken Sufu expression was detected using Chicken-specific RT-qPCR primers at
days 10, 14 and 17 of RA treatment in pcDNA and pSUFU stably transfected Sufu-/- cells.
(B) Gli3 full-length (Gli3FL) and repressor (Gli3R) was detected at days 10, 14 and 17 of
RA in pGli3 stably transfected Sufu-/- cells. N=3. Bars represent mean values  s.e.m. Pvalues were determined by Student’s t-test. **P<0.01, ***P<0.001.
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Figure 2-15: Sufu or Gli3 overexpression partially rescues the Sufu-/- phenotype
(A) Immunoblot of GFAP on days 10, 14 and 17 in WT and Sufu-/- KO clone #2 cells
stably transfected with pcDNA empty vector (pcDNA), pcDNA-chicken Sufu (pSUFU),
or pcDNA-human Gli3 (pGli3) vectors and treated with RA. (B) Densitometric analysis
of GFAP from the immunoblot in A. N=3. Bars represent mean values  s.e.m. P-values
were determined by One-way ANOVA with Tukey’s post-hoc analysis. *P<0.05,
**P<0.01, ****P<0.0001.
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2.4

Discussion

Hh signaling is involved in neural tube closure and neural differentiation in vivo (Wilson
and Maden 2005; Briscoe and Thérond 2013) where its activation results in transcription
of target genes through Glis (Humke et al. 2010; Briscoe and Thérond 2013). Negative
regulators of the pathway include Patched and SUFU (Briscoe and Thérond 2013), the
loss of which results in medulloblastoma and Nevoid Basal Cell Carcinoma Syndrome
(Hahn et al. 1996; Taylor et al. 2002; Urman et al. 2016; Smith et al. 2018). Using the
mouse P19 cell model we report that Hh pathway activity is required for neural
differentiation but increasing Hh pathway activity alone is not sufficient to induce neural
cell fates. Furthermore, SUFU was found to be essential for in vitro neural differentiation
as its loss caused the loss of Gli3, the induced transcription of Hh target genes and
perturbed timing and proportion of astrocyte differentiation. Furthermore, human Gli3
overexpression was sufficient to rescue GFAP, the astrocyte marker, in these SUFU
deficient mouse cells, which indicates that Gli3 acts downstream or in parallel to the
negative regulation imparted by SUFU.
RA-induced neural differentiation of P19 cells is well established (Jones-Villeneuve et al.
1982; McBurney et al. 1982, 1988; McBurney 1993), however few studies have explored
Hh signaling in the model (Tan et al. 2010; Voronova et al. 2011; Lin et al. 2012).
Voronova and colleagues (Voronova et al. 2011) also explored expression of Gli
transcription factors during RA induced neurogenesis, and we have added to that work by
reporting timeline expression of all components of the pathway. Specifically, we
demonstrated that RA induced Shh expression (Figure 2-3A) where RA likely acts in
these cells through the transcription factor FOXA1, which promotes the early expression
of Shh (Tan et al. 2010); two other messages encoding Hh ligands (Dhh and Ihh) were
also expressed (Figure 2-3A). IHH and DHH, like SHH, can activate the pathway as
evident in long bone differentiation (St-Jacques et al. 1999; Bechtold et al. 2019) and
gonad development (Bitgood et al. 1996; Clark et al. 2000; Bashamboo and McElreavey
2015). Similar results showing transcriptional activation of all Hh ligands was reported
with human embryonic stem cells (hESCs) induced to form neural tissues (Wu et al.
2010). Thus, it is likely that SHH is responsible, but since transcripts encoding all ligands

111

are induced by RA it remains unclear which isoform triggers pathway activation in the
P19 model. Although we, like others, have demonstrated the presence of Hh signaling in
P19 differentiation, other signaling pathways including those linked to Wnt, Fgf and Yap
are also involved (Tang et al. 2002; Chen et al. 2006; Jing et al. 2009; Lin et al. 2012).
Considering our study, these other pathways require further investigation to determine if
they too are temporally regulated to facilitate differentiation.
Utilization of RA to induce neural lineages in vitro goes beyond the P19 model, as RA is
used for directed neural differentiation of human induced pluripotent stem cells and
mouse embryonic stem cells (mESCs) (Fraichard et al. 1995; Mak et al. 2012). Many
neural differentiation protocols also supplement RA with exogenous SHH or SAG in
order to enhance the differentiation of neurons (Okada et al. 2004; Mak et al. 2012; Wu et
al. 2012) and glial cell progenitors (Li et al. 2019). Like these previous results, cotreating P19 cells with RA and SAG at day zero in our protocol enhanced the
differentiation of both neurons and astrocytes (Figure 2-4), although treating with SAG
alone was not sufficient to induce differentiation. We also investigated the effect of
inhibiting the Hh pathway using Cyc, where Cyc treatment inhibited neuron and astrocyte
differentiation (Figure 2-4), a result consistent with previous work showing Cyc cotreatment with RA decreased expression of neural-related transcription factors in mESCs
(Okada et al. 2004). In vivo studies also highlight the requirement of Hh signaling in
neural differentiation and development, where mutations reducing Hh activity causes
reduced neuron differentiation in the embryonic midbrain (Gazea et al. 2016), reduced
neural progenitors in the developing cerebellum (Spassky et al. 2008), reduced
neurogenesis of the developing telencephalon (Komada et al. 2008; Xu et al. 2010) or
large-scale alterations to the size of interneuron differentiation regions in the neural tube
(Ding et al. 1998; Rallu et al. 2002). Thus, the early activation of Hh signaling in the
differentiation of neural lineages is a requirement, and we next sought to understand the
importance of later-stage reduction of the Hh signal by SUFU.
SUFU regulation of Hh signaling involves the ubiquitin-proteasome pathway following
Hh pathway activation (Yue et al. 2009). We showed Hh ligand expression is induced
within 1 day of RA treatment (Figure 2-2) and given previous reports on SUFU
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regulation, an early decrease in SUFU levels was expected. Our results, however, showed
no significant change in SUFU levels during any stage of neurogenesis in P19 cells
(Figure 2-6). Thus, it is likely that SUFU is being regulated through post-translational
modifications to affect Hh signaling output, and although not explored here, it should be
noted that differential phosphorylation and ubiquitination can both promote or inhibit
SUFU stability and/or Gli interaction (Takenaka et al. 2007; Chen et al. 2011; Wang et al.
2016; Infante et al. 2018). CRISPR-Cas9, used to deplete SUFU from P19 cells, showed
the loss of SUFU induces the ectopic transcription of Hh target genes (Figure 2-7, Figure
2-10, Figure 2-11) and while supported by studies using mice, mESCs and hESCs (Chen
et al. 2009; Wu et al. 2010; Hoelzl et al. 2015; Urman et al. 2016; Hoelzl et al. 2017), this
is in contrast with a study showing reduced Hh target expression in adult neural stem
cells (Noguchi et al. 2019) and in another showing loss of Sufu reducing maximal Hh
pathway activity in the developing mouse spinal cord (Zhang et al. 2017). Given previous
work showing Gli2 overexpression in P19 cells is sufficient to induce neuron
differentiation in the absence of RA (Voronova et al. 2011), we were surprised to observe
SUFU-deficient P19 cells did not differentiate towards the neuron lineage in the absence
of RA (Figure 2-12A). That another study showed the knockdown of Gli2 in YAP
overexpressing P19 cells causes an increase in neuron differentiation (Lin et al. 2012),
would indicate that other Gli’s may be involved in the neural differentiation of P19 cells,
specifically Gli3.
The connection between aberrant astrocyte differentiation and SUFU deficiency came
from examining the transcriptional activation of Hh target genes (Figure 2-7, Figure 2-10,
and Figure 2-11). Gli1 and Ptch1 expression was higher when Sufu was knocked out, but
not Gli3 (Figure 2-10). Previous reports in mouse embryonic fibroblasts and mouse
embryos show that SUFU is required for proper Gli3 processing (Kise et al. 2009) and its
absence leads to reduced or absent Gli3 protein (Chen et al. 2009; Makino et al. 2015),
which also occurs with conditional Sufu knockouts in the embryonic and post-natal
mouse brain (Kim et al. 2011, 2018; Yabut et al. 2015; Jiwani et al. 2020). We reported
similar results with Gli3 in P19 cells and showed that it affects neural differentiation. In
support, conditional knockouts of Sufu at various stages of mouse brain development
results in decreased neuron differentiation and disorganized glial cell arrangements in the
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cerebellum and forebrain (Yabut et al. 2015; Kim et al. 2018). Discrepancies, however,
do exist even within Hh signaling in P19 cells (Voronova et al. 2011; Lin et al. 2012),
and although these differences can be explained, our work has shown the knockout of
Sufu was accompanied by the consistent upregulation of Hh target genes, like that seen in
mouse retinal progenitor cells (Cwinn et al. 2011), mESCs (Hoelzl et al. 2015) and the
developing mouse neocortex (Yabut et al. 2015) lacking SUFU. This upregulation did not
result in neuron differentiation without RA treatment (Figure 2-12A) and this result is
supported by work in SUFU-deficient mESCs (Hoelzl et al. 2015) and SHH treated
hESCs (Wu et al. 2010) maintaining their pluripotent state without additional
differentiation cues. Our results did show a delay and decrease in astrocyte differentiation
with SUFU loss (Figure 2-12 and Figure 2-13), which may explain the disorganization of
glial cells observed in conditional Sufu knockouts described in mouse embryos (Yabut et
al. 2015; Kim et al. 2018). However, previous work has shown the same reduction in
astrocyte differentiation in P19 cells overexpressing a dominant negative form of Gli2,
thus causing a reduction in Hh pathway activity (Voronova et al. 2011). This, combined
with our work, shows that Hh signaling is induced by RA and this induction is required
for differentiation. The Hh pathway, however, must return to basal activity levels for
proper astrocyte differentiation to occur. Given that glial cell populations are composed
of astrocytes, oligodendrocytes and microglia, further research must be done to explore
the effect of SUFU loss on these other lineages. In the developing mouse forebrain, an
initial report suggests an essential role of SUFU in oligodendrocyte differentiation,
however the molecular mechanisms involved remain to be resolved (Winkler et al. 2018).
In addition to the delay in astrocyte formation (Figure 2-12 and Figure 2-13), there was a
loss of Gli3 in SUFU-deficient cells (Figure 2-10 and Figure 2-11) and we have provided
evidence that ectopic expression of Gli3 was sufficient to rescue the timing of glial cell
differentiation (Figure 2-15). That GLI3 was able to rescue the Sufu knockout phenotype
is significant and supported by previous research showing Gli3 repressor overexpression
in the SUFU-deficient embryonic mouse cerebellum was sufficient to rescue morphology
and increase GFAP levels (Kim et al. 2011). Together, our results show that SUFU
imparts a negative regulation on the Hh pathway, likely by acting on Gli3, and is required
during the specification of the astrocyte lineage.
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Chapter 3

3

Never in Mitosis Kinase 2 regulation of metabolism is
required for neural differentiation

Wnt and Hh are known signalling pathways involved in neural differentiation and recent
work has shown the cell cycle regulator, Never in Mitosis Kinase 2 (Nek2) is able to
regulate both pathways. Despite its known function in pathway regulation, few studies
have explored Nek2 within embryonic development. The P19 embryonal carcinoma cell
model was used to investigate Nek2 and neural differentiation through CRISPR knockout
and overexpression studies. Loss of Nek2 reduced cell proliferation in the
undifferentiated state and during directed differentiation, while overexpression increased
cell proliferation. Despite these changes in proliferation rates, Nek2 deficient cells
maintained pluripotency markers after neural induction while Nek2 overexpressing cells
lost these markers in the undifferentiated state. Nek2 deficient cells lost the ability to
differentiate into both neurons and astrocytes, although Nek2 overexpressing cells
enhanced neuron differentiation at the expense of astrocytes. Hh and Wnt signaling were
explored, however there was no clear connection between Nek2 and these pathways
causing the observed changes to differentiation phenotypes. Mass spectrometry was also
used during wildtype and Nek2 knockout cell differentiation and we identified reduced
electron transport chain components in the knockout population. Immunoblotting
confirmed the loss of these components and additional studies showed cells lacking Nek2
were exclusively glycolytic. Interestingly, hypoxia inducible factor 1 was stabilized in
these Nek2 knockout cells despite culturing them under normoxic conditions. Since
neural differentiation requires a metabolic switch from glycolysis to oxidative
phosphorylation, we propose a mechanism where Nek2 prevents HIF1 stabilization,
thereby allowing cells to use oxidative phosphorylation to facilitate neuron and astrocyte
differentiation.
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3.1 Introduction
Hedgehog (Hh) and Wnt signaling pathways are vital for neural development and are
involved during in vivo and in vitro neural differentiation (Schuuring et al. 1989;
Dahmane and Ruiz 1999; Tang et al. 2002; Min et al. 2011; Kim et al. 2018). During
neurulation the notochord and floor plate secrete Hh, inducing ventral neural phenotypes,
and the roof plate secretes Wnt, inducing dorsal neural phenotypes (Wilson and Maden
2005; Mulligan and Cheyette 2012; Briscoe and Thérond 2013). These signals not only
pattern the dorsal-ventral axis of the neural tube but are also vital for patterning its
anterior-posterior axis (Mulligan and Cheyette 2012) and defining the midbrain-hindbrain
boundary (Kim et al. 2011; Gibbs et al. 2017). Activation of the Hh pathway occurs when
the Hh ligand binds to its receptor Patched (Ptch), which relieves the inhibition of
Smoothened, allowing Smoothened to translocate to the plasma membrane (Rohatgi et al.
2007). Translocation causes the Suppressor of Fused (SUFU) and Gli complex to be
recruited to the primary cilium where SUFU dissociates from the full-length form of Gli,
which enters the nucleus to activate transcription (Humke et al. 2010; Tukachinsky et al.
2010). In the absence of ligand, SUFU-bound Gli is either sequestered in the cytoplasm
or is targeted for partial proteosomal degradation converting Gli to a transcriptional
repressor (Hui and Angers 2011; Briscoe and Thérond 2013). In the case of the Wnt
pathway, it is either canonical and involves -catenin or non-canonical and linked to
planar cell polarity or Ca2+ signaling. In either case, one of 19 vertebrate Wnt ligands
binds the transmembrane receptor Frizzled (Fzd), which signals to Dishevelled (DVL)
and in the canonical pathway causes the recruitment of the destruction complex (Cliffe et
al. 2003; Wong et al. 2003; Stamos and Weis 2013) that includes Axin, adenomatous
polyposis coli, glycogen synthase kinase 3 (GSK3), casein kinase 1, and -TrCP, a
ubiquitin ligase (Stamos and Weis 2013; Mukherjee et al. 2018). This recruitment and the
destabilization of Axin attenuates the hyper-phosphorylation of -catenin by GSK3
allowing -catenin cytoplasmic accumulation and translocation to the nucleus where it
interacts with TCF/LEF transcription factors inducing Wnt target gene transcription
(Steinhart and Angers 2018).
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Recently, Never in Mitosis Kinase 2 (Nek2) was reported as a novel regulator of both
canonical Wnt and Hh pathways (Mbom et al. 2014; Cervenka et al. 2016; Wang et al.
2016; Zhou et al. 2017), but few studies have explored its role in embryonic
development. What is known, however, is that Nek2 plays an essential role in left-right
asymmetry of the Xenopus heart (Joseph Endicott et al. 2015a), its overexpression in the
Drosophila eye ectopically induces wingless (Wnt1) signaling and reduces retinal neuron
differentiation (Martins et al. 2017), and in mouse, Nek2 expression is reported in the
brain of the E10.5 embryo (Tanaka et al. 1997). The role of this protein in signaling,
however, originated from reports of its involvement as a centrosomal linker protein
during the cell cycle, showing Nek2 binding and phosphorylating DVL (Cervenka et al.
2016) and -catenin (Mbom et al. 2014) at centrosomes. Nek2, serving as a Gli1/2 target
gene (Zhou et al. 2017), also phosphorylates and stabilizes SUFU (Wang et al. 2016),
placing it as negative regulator of the Hh pathway. Overexpression of Nek2 has also been
linked to multiple Wnt- and Hh-associated cancers, including those causing brain
malignancies (Neal et al. 2014; Lin et al. 2016; Boulay et al. 2017; Liu et al. 2017; Yao et
al. 2019; Xiang et al. 2022).
Given that Hh and Wnt signaling are essential in neural differentiation, and that Nek2
acts as a regulator of both pathways, we sought to explore the role of Nek2 in neural
differentiation using P19 embryonal carcinoma cells. These cells can be differentiated
towards neurons and astrocytes in the presence of retinoic acid (RA) (Jones-Villeneuve et
al. 1982, 1983; McBurney et al. 1988; McBurney 1993; Spice et al. 2022), which affects
Wnt (Schuuring et al. 1989; St-Arnaud et al. 1989; Papkoff 1994; Tang et al. 2002) and
Hh (Voronova et al. 2011; Spice et al. 2022) signaling. Herein, we report the presence of
Nek2 throughout RA-induced differentiation and through overexpression studies and
CRISPR-Cas9 ablation, demonstrate an essential role of Nek2 in neuron and astrocyte
differentiation. Furthermore, we show that Nek2 overexpression is linked to increased
Wnt signaling, however, proteomic analysis suggests an essential role of Nek2 outside of
signaling and connects its involvement to metabolic regulation.
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3.2
3.2.1

Materials and Methods
Cell Culture

Mouse P19 embryonal carcinoma cells were a generous gift from Dr. Lisa Hoffman,
Lawson Health Research Institute, UWO. Cells were maintained in DMEM containing
5% fetal bovine serum (FBS, ThermoFisher) and 1% penicillin/streptomycin
(ThermoFisher) on adherent tissue culture plates (Sarstedt). Wildtype and mutant cells
were passaged every 4 days or when they reached a confluency of 70%, whichever
occurred first. Following previously published protocols (McBurney et al. 1982; Spice et
al. 2022), differentiation was induced in wildtype and mutant cells by plating 1.05 × 106
cells on bacterial grade Petri dishes (Falcon) in the presence of 0.5 μM retinoic acid (RA)
for 4 days to form embryoid bodies (EB). These aggregates were collected and re-plated
on adherent tissue culture dishes in the presence of 0.5 μM RA, which in wildtype cells,
develop into neurons after 10 days and form astrocytes by day 17. For BIO-treated
experiments, cells were induced to differentiate in the presence of 0.5 μM RA on days 0
and 4, 0.5 μM RA treatments on days 0 and 4 plus 10 nM BIO (6-Bromoindirubin-3′oxime, Sigma) treatment on day 0, or 10 nM BIO treatment on day zero plus 0.5 μM RA
on day 4. Cells were also treated with 10 nM BIO alone with no subsequent RA. For
XAV treatments, cells were induced to differentiate in the presence of 0.5 μM RA on
days 0 and 4, plus 5 μM XAV on day 0. For metabolic experiments cells were seeded and
allowed to adhere for 16 hours, then treated with either media alone, DMSO, 2.5 μM
Oligomycin A (BioShop) or 50 mM 2-Deoxy-D-glucose (2-DG, Sigma) for 24 hours.
Cell counts and viability were measured by trypan blue exclusion. Cells for all
experiments were maintained at 37C and 5% CO2.

3.2.2

Preparing CRISPR plasmids

Nek2 sgRNAs (Table 3-1) were cloned into the CRISPR-Cas9 plasmid pSpCas9(BB)2A-Puro (PX459) V2.0 (Addgene plasmid 62988; http://n2t/addgene:62988) using the
protocol by Ran et al. 2013 (Ran et al. 2013). Prior to cloning, sgRNAs were amplified
and phosphorylated, then subsequently digested with the BbsI restriction enzyme along
with the vector. Digested sgRNA and vector were incubated at room temperature for 1.5
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hours in the presence of T7 ligase (New England Biolabs). Plasmids were transformed
into transformation competent DH5alpha E. coli cells and positive colonies were
collected using a Mini Prep kit (Qiagen) and sequenced using the U6 primer (Table 3-1)
at the London Regional Genomics Centre (Robarts Research Institute, London, ON).
Table 3-1: CRISPR-Cas9 gRNAs, primers for gRNA amplification and PCR around
the cut site
Nek2 KO
gRNA
Nek2 KD
gRNA
Nek2 KO
gRNA
Nek2 KO
PCR
Nek2 KD
gRNA
Nek2 KD
PCR
U6

3.2.3

CRISPR-Cas9
CATCGTAATGGAATACTGTGAGG
CAAGCCATCAGAGTAGCGGTAGG
Forward Primer (5’ → 3’)
CACCCATCGTAATGGAATACTGTGAGG

Reverse Primer (5’ → 3’)
AAACCCTCACAGTATTCCATTACGATG

TTTGTCTCACACCTTGGAAATG

TTATTAGATACGAACCGTGGGG

CACCCAAGCCATCAGAGTAGCGGTAGG

AAACCCTACCGCTACTCTGATGGCTTG

CTGCAGAATGTCCAGAGCGT

CTGTAGCCAGGGAAACCGAT

GGGCAGGAAGAGGGCCTAT

Generating Nek2 deficient cell lines

Two μg of sgRNA containing plasmid was incubated with 10 μL of Lipofectamine 2000
(Invitrogen) for 20 minutes and then added to high confluency P19 cells for 4 hours.
Culture media was replaced, and cells were allowed to reach 70% confluency. Cells were
then passaged to a 1 cell/50 μL concentration into a 96 well plate where they were
incubated daily in 1 μg/mL puromycin (BioShop) selection medium for 4 days. After
selection, cells were allowed to recover in compete medium until reaching 70%
confluence. Mutant genotypes were identified by collecting genomic DNA (Qiagen
DNeasy Blood & Tissue kit, 69504), which was amplified using PCR (DreamTaq Master
Mix (2X), Thermo Scientific, K1081), a vapo.protect Thermocycler (Eppendorf) and sitespecific primers (Table 3-1). Amplified DNA was sequenced at the London Regional
Genomics Centre and pair-wise alignments were performed using Geneious 2021™.
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Additional analysis of in/dels was performed using Synthego Performance Analysis, ICE
Analysis. 2019. v3.0. Synthego; [Jan. 13, 2022].

3.2.4

Generating Nek2 Overexpression Cell Line

Two μg of plasmid was incubated in the presence of 10 μL of Lipofectamine 2000 for 4
hours. Media was changed and cells were allowed to grow to 70% confluency before
being passaged. Cells were incubated in selection media containing either 1 mg/mL
hygromycin or 500 μg/mL neomycin for 2 weeks, with selection media being changed
every 48 hours, to generate stable lines. Plasmids used include: 1436 pcDNA3 Flag HA
(Addgene plasmid #10792) and pCMV3-human NEK2-Myc (HG10054-CM, Sino
Biological).

3.2.5

RT-qPCR

Real time reverse transcriptase PCR analysis was used to determine relative expression
levels of various genes accompanying differentiation in wildtype and mutant cell lines. In
wildtype cells, mRNA was collected at days 0, 1, 2, 3, 4, 6, 8 and 10 after RA treatment
and in wildtype and mutant cells, mRNA was collected at days 0, 10, 14 and 17 after RA
treatment using QIAshredder (Qiagen, 79654) and RNeasy (Qiagen, 74104) kits. RNA
was reverse-transcribed into cDNA using a High-Capacity cDNA Reverse Transcription
Kit (ThermoFisher Scientific, 4368814) and was amplified using the following primers:
L14, Nek2, Gli1, Ptch1, Ascl1, Dab2, Dkk1, c-Myc, Nanog and Oct4 (Table 3-2). PCR
reactions containing 500 nM each of reverse and forward primers, 10 μL of SensiFAST
SYBR No-ROX Mix (FroggaBio, BIO-98050) and 1 μL of cDNA, were run using a CFX
Connect Real-Time PCR Detection System (Bio-Rad). Samples were analyzed using the
comparative cycle threshold method (2-ΔΔCt) using L14 as an expression control and
comparing normalized expression values to undifferentiated wildtype cells to determine
fold changes in expression.

127

Table 3-2: Primers used for RT-qPCR
qRT-PCR
Gene

Forward Primer (5’ → 3’)

Reverse Primer (5’ → 3’)

L14

GGGTGGCCTACATTTCCTTCG

GAGTACAGGGTCCATCCACTAAA

Gli1

GGAAGTCCTATTCACGCCTTGA

CAACCTTCTTGCTCACACATGTAAG

Ptch1

AAAGAACTGCGGCAAGTTTTTG

CTTCTCCTATCTTCTGACGGGT

Oct4

CCCAATGCCGTGAAGTTGGA

GCTTTCATGTCCTGGGACTCCT

Nanog

TCTTCCTGGTCCCCACAGTTT

GCAAGAATAGTTCTCGGGATGAA

Dkk1

TGAAGATGAGGAGTGCGGCTC

GGCTGTGGTCAGAGGGCATG

Dab2

GGAGCATGTAGACCATGATG

AAAGGATTTCCGAAAGGGCT

3.2.6

Immunoblotting

Cells at various stages of differentiation in both wildtype and mutant lines were lysed
using 100-500 μL of 2% sodium dodecyl sulfate buffer with 10% glycerol, 5% 2mercaptoethanol, 1:200 of 1X Halt Protease Inhibitor Cocktail (ThermoFisher Scientific,
1862209), at pH 6.8. Proteins were sonicated on ice for 30 seconds and quantified using a
DC™ Protein Assay (Bio-Rad, 5000113) before loading 10 μg of protein to 6-10%
polyacrylamide gels. Proteins were separated for approximately 1.5 hours at 120V, and
then transferred overnight at 20V to PVDF membranes (Bio-Rad, 1620177). Membranes
were placed for 1 hour at room temperature in 5% skim milk in Tris-buffered saline
containing 0.1% Tween-20 (TBS-T). After washing, blots were incubated overnight at
4 C in the following primary antibodies: -III-Tubulin (TUJ1, 1:1000; Cell Signaling
Technology, 5568), SUFU (1:1000; abcam, ab28083), GFAP (1:1000; Invitrogen, 149892-80), Nek2 (Santa Cruz Biotechnology, sc-55601), Dab2 (Cell Signaling
Technology, 12906), ERRB (1:1000; Novus Biologicals, PP-H6705-00), Total OXPHOS
(1:1000; acbam, ab110413), TOM20 (1:1000; Cell Signaling Technology, 42406), HIF1
(ab179483) and -actin (1:10,000; Santa Cruz Biotechnology, sc-47778). Blots were
washed and then incubated for 2 hours at room temperature in host-specific HRPconjugated secondary antibody (1:10,000, Sigma) in TBS-T containing 5% skim milk.
After secondary antibody incubation and washing, blots were incubated in Immobilon®
Classico Western HRP Substrate (Millipore, WBLUC0500) and imaged using a Chemi
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Doc Touch System (Bio-Rad). Densitometry analysis was performed using ImageLab
Software (Bio-Rad).

3.2.7

Immunofluorescence and Phase Contrast Imaging

Wildtype and Nek2 knockout cells were treated with 0.5 μM RA as described (Spice et
al. 2022) for 17 days on poly-L-lysine hydrobromide (Sigma, P5899) coated coverslips.
Cells on coverslips were washed with PBS for 1 minute and then fixed with 4%
paraformaldehyde in PBS for 10 minutes at room temperature. Ice-cold PBS was used to
wash coverslips, then cells were permeabilized with 0.2% Triton-X-100 in PBS for 10
minutes at room temperature. Cells were again washed before being blocked for 30 mins
at room temperature in PBS containing 1% bovine serum albumin, 22.52 mg/mL glycine
and 0.1% Tween-20. Coverslips were then incubated overnight in a humidity chamber
with the following primary antibodies: -III-Tubulin (TUJ1, 1:400; Cell Signaling
Technology, 5568) and GFAP (1:500; Invitrogen, 14-9892-80). After primary incubation,
cells were washed and incubated with secondary antibodies in blocking solution for 1
hour at room temperature. The secondary antibodies were Alexa Fluor™ 660 Goat antiMouse IgG (Invitrogen, A21054) and Goat anti-Rabbit IgG Alexa Fluor Plus 488
(Invitrogen, A32731TR). Finally, coverslips were washed and mounted to slides using
Slowfade™ Gold Antifade Mountant with DAPI (Invitrogen, S36942) and sealed with
nail polish. Images were captured on a Zeiss AxioImager Compound Fluorescence
Microscope (Integrated Microscopy Facility, Biotron, Western University, London, ON).
Wildtype and Nek2 mutant cells were treated with RA as described above, and after 4
days, EBs were imaged using a Leica DMIL LED microscope or a Zeiss inverted
microscope and an OPTIKA Microscopes C-B5 camera with OPTIKA Lightview
software. EB number per image area, EB area and aspect ratio were measured using
ImageJ.

3.2.8

Cell Count and Viability Assays

Trypan blue exclusion assays were performed on wildtype and mutant cells in the
undifferentiated state, after 4 days of RA treatment and after 2-DG or Oligomycin A
treatment. In the undifferentiated state, 15,000 cells were plated on adherent tissue
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culture dishes. Every 24 hours for 96 hours, cells were trypsinized and a 1:1 cell
suspension to trypan blue ratio was added and total number of cells counted using a
CellDrop BF Brightfield Cell Counter (DeNovix). For RA treatment, cells were
processed as described previously (Spice et al. 2022) and EBs were collected after 4 days.
EBs were vigorously resuspended in complete media, before being counted in a 1:1 cell
suspension to trypan blue ratio. Total cell number was counted, and viability was
compared to the number of dead cells.

3.2.9

Caspase 3 Activity Assay

Caspase 3 activity was measured using the Caspase-3 Colorimetric Activity Assay Kit
(APT131, Millipore). Briefly, cells were treated with RA for 4 days to form EBs, and
then collected and lysed according to manufacturer’s instructions. Caspase-3 activity was
determined through the detection of p-nitroaniline (pNA) in cytoplasmic lysates after
incubation with a Caspase-3 specific substrate (Ac-DEVD-pNA). Readings were
performed using a Modulus™ II Microplate Multimode Reader (Turner Biosystems) at
450nm, where background detection was subtracted and normalized to wildtype Caspase3 activity.

3.2.10

Luciferase Assay

Wildtype and Nek2 mutant cells were transfected with 4 μg total of DNA using 10 μL of
Lipofectamine 2000. Transfected plasmids included pRL-TK (Promega) alone, or pRLTK and pGL3-BARL (-catenin activated reporter luciferase, Promega) or pRL-TK and
pGL3-8xGli (a gift from Philip Beachy, Stanford University). Following transfection,
cells were incubated for 24 hours before passaging into a 96-well plate. Cells were
allowed to adhere for 48 hours before the Dual-Gli® Luciferase Assay System (Promega,
E2920) was used according to manufacturer’s instructions. Briefly, Dual-Glo reagent was
incubated in each well containing growth media for 15 minutes before measuring Firefly
luminescence (from pGL3-BARL and pGL3-8xGli plasmids). Subsequently, Dual-Glo
Stop & Glo reagent was added to each well and was incubated for 15 minutes before
measuring Renilla luminescence (from pRL-TK plasmid). To calculate initial
luminescence values, background luminescence was subtracted from each well, where
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Firefly luminescence was divided by Renilla luminescence for each treatment. Relative
luminescence was determined by dividing each well by the luminescence from WT cells
transfected with pRL-TK only.

3.2.11

LC-Mass Spectrometry

Cells were differentiated as described, and cells were either centrifuged as EBs for
collecting cells at days 1 and 4 of RA treatment or were trypsinized and centrifuged for
adherent cells at days 0 and 10 of RA treatment. Three biological replicates of lysates of
P19 cells were prepared through incubation in 8 M Urea, 50 mM ammonium bicarbonate
(ABC), 10 mM DTT, 2% SDS at room temperature for 10 minutes and sonicated with a
probe sonicator for 20 x 0.5s pulses to shear DNA. Lysates were quantified by using a
PierceTM 660 nm Protein Assay (ThermoFisher Scientific) and stored at –80C until
future use. Lysates were reduced in 10 mM DTT for 30 min and alkylated in 100 mM
iodoacetamide (IAA) for 30 min at room temperature in the dark. Next, lysate protein
was precipitated in chloroform/methanol and prepared for in-solution digestion according
to Kuljanin et al. (Kuljanin et al. 2017). On-pellet protein digestion was performed in 50
mM ABC (pH 8) by adding TrypLysC (Promega) at an enzyme: protein ratio at 1:25 and
incubated overnight at 37C in a ThermoMixer at 900rpm. Digestion buffer was acidified
to 1% formic acid (FA) and vacuum centrifuged at 45⁰C. Digested peptides were desalted
using in-house C18 stagetips prepared in a 200µl pipette tip. C18 stagetips were
conditioned with 80% Acetonitrile (ACN)/0.1% trifluoracetic acid (TFA) followed by
5% ACN/0.1%TFA before loading and washing peptides twice with 5% ACN/0.1%TFA.
Desalted peptides were eluted with 80%ACN/0.1% TFA prior to vacuum centrifugation
and resuspension in 0.1% FA. Final peptide concentrations were determined by BCA
quantification prior to ultraperformance liquid chromatography tandem mass
spectrometry (UPLC-MS/MS).
500ng of peptides per sample was analyzed by using an M-class nanoAquity UPLC
system (Waters) connected to a Q Exactive mass spectrometer (Thermo Scientific).
Buffer A consisted of Water/0.1% FA and Buffer B consisted of ACN/0.1% FA. Peptides
were loaded onto an ACQUITY UPLC M-Class Symmetry C18 Trap Column (5µm, 180
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m x 20 mm) and trapped for 5 min at a flow rate of 10 L/min at 99% A/1% B.
Subsequently, peptides were separated on an ACQUITY UPLC M-Class Peptide BEH
C18 Column (130 A, 1.7 µm, 75µm × 250 mm) operating at a flow rate of 300 nL/min at
35⁰C using a non-linear gradient consisting of 1–7% B over 1 min, 7–23% B over 179
min, 23–35% B over 60 min, 35-98% B over 5 minutes, before increasing to 95% B and
washing. Settings for data acquisition on the Q Exactive are outlined in Table 3-3. Raw
UPLC-MS/MS files were processed in FragPipe 1.18.0 and data analysis was performed
in Perseus software (v1.16.4). Statistical significance was determined using Student’s ttest (p<0.05). Gene Set Enrichment Analysis (GSEA) using GSEA 4.2.3 was used to
reference GO Biological Processes using Signal2Noise for ranking genes, all other
settings were left at default.
Table 3-3: Q Exactive Settings for Data Acquisition
QE Plus Setting

Value

Scan Range

400-1500 m/z

MS1 AGC Target

3E6

MS1 Resolution

70K

MS2 Resolution

17.5K

MS2 AGC Target

2E5

Maximum IT

64ms

Loop Count

12

Top N

12

Isolation Window

1.2 m/z

Isolation Offset

0.5 m/z

NCE

25

Dynamix Exclusion

30

Charge Exclusion

1,7,8,>8

Fixed First Mass

100 m/z
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3.2.12

Statistical Analysis

One-way ANOVA with Tukey’s post-hoc analysis was used for wildtype timeline
experiments and experiments containing only 3 groups. For experiments comparing
expression or protein abundance over time across two cell lines a Two-way ANOVA was
used with Sidak’s multiple comparisons post-hoc analysis. All statistical analyses were
performed using Prism Software (Prism version 9.3.1).

3.3
3.3.1

Results
Nek2 levels are unchanged during neural differentiation

Despite the reports showing that Nek2 regulates Hh and Wnt signaling (Mbom et al.
2014; Cervenka et al. 2016; Wang et al. 2016; Zhou et al. 2017) and both pathways are
activated during P19 neural differentiation (Schuuring et al. 1989; Voronova et al. 2011;
Spice et al. 2022), few publications have explored the role of Nek2 in embryonic
development (Tanaka et al. 1997; Joseph Endicott et al. 2015b; Martins et al. 2017) and
to our knowledge, few limited work exists on its involvement in neurogenesis. To first
address this shortfall, Nek2 gene expression (Figure 3-1) and protein levels (Fig. 3-2A
and B) were explored throughout RA-induced differentiation, and results showed no
significant change in either transcript or protein levels.

133

Figure 3-1: Nek2 gene expression does not change throughout RA-induced neural
differentiation
RT-qPCR of Nek2 during days 0-17 of RA treatment. N=3. Bars represent mean values 
s.e.m. Significance was determined by One-way ANOVA with Tukey’s post-hoc
analysis.
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Figure 3-2: Nek2 levels do not change during neural differentiation
(A) Immunoblot of Nek2 at various timepoints between days 0-17 of RA treatment. (B)
Densitometry of immunoblot in A. N=3. Bars represent mean values  s.e.m. P-values
were determined by One-way ANOVA using Tukey’s post-hoc analysis.
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3.3.2

Nek2 regulates cell proliferation in undifferentiated cells

To determine the role of Nek2 in P19 cells, CRISPR-Cas9 was used to disrupt exon 2 of
the coding region of the gene (gRNA sequence Table 3-1). This targeting resulted in a
pool of alleles that consisted primarily of a 10 bp deletion, but also contained alleles of 1,
2, 8, 11, 17 and 18 bp deletions, as well as 5, 7 and 8 bp insertions (Figure 3-3A). This
polyclonal pool was labelled knockout (KO) as all alleles resulted in a frameshift
mutation and immunoblotting showed no detection of Nek2 protein in these cells (Fig. 34A and B). A second gRNA, targeting exon 3 (Table 3-1), resulted in a reduction in Nek2
levels (Fig. 3-4A and B) and identified alleles within these cells were either wildtype
(WT) sequence or a 1 bp insertion (Figure 3-3B). These cells were labelled as
knockdown (KD) cells and although the nature of the knockdown was not explored
further, it may be the result of heterozygous alleles or in defects in pre-mRNA splicing
(Tang et al. 2018). Cells were also transfected with either pcDNA or a plasmid containing
human Nek2 (pNek2-Myc), the latter showing significantly increased levels of Nek2
protein over the pcDNA control (Fig. 3-4A and B).
As Nek2 is a known regulator of the cell cycle (Fry et al. 2012), cell counts were
performed in undifferentiated cells, and results show that the Nek2 KO caused
significantly fewer cells to be present after 72 and 96 hours (Fig. 3-4C); KD cells had
significantly fewer cells only after 96 hours (Fig. 3-4C). Nek2-overexpressing cells
showed the opposite results, with more cells present than the control at 96 hours (Fig. 34C). Thus, Nek2 loss resulted in decreased cell proliferation while its overexpression
caused the opposite effect.
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Figure 3-3: Allele summary of NEK2 deficient cells
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Synthego ICE analysis showing alleles in the population of (A) Nek2 knockout (KO) and
(B) Nek2 knockdown (KD) cells. Orange lines show WT sequence similarity to projected
region, green lines show mutant sequence similarity. Dotted black line highlights the
predicted cut site. Blue bars represent percentage of identified pool with the noted in/del.
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Figure 3-4: Altering Nek2 levels changes proliferation rate of undifferentiated cells
(A) Immunoblots of Nek2 in wildtype (WT), knockout (KO), knockdown (KD), pcDNA
and hNek2-Myc transfected cells in the undifferentiated state. (B) Densitometry of
immunoblots in A. Bars represent mean values  s.e.m. P-values were determined by
One-way ANOVA using Tukey’s post-hoc analysis. (C) Total cell counts of WT, KO,
KD, pcDNA and hNek2-Myc transfected cells between 0-96 hours after plating in the
undifferentiated state. Dots represent mean values  s.e.m. P-values were determined by
Two-way ANOVA using Sidak’s post-hoc analysis. *P<0.05, **P<0.01, ***P<0.001,
****P<0.0001.
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The reduction in cell number in KO and KD cells was also observed after 4 days of RA
treatment (Figure 3-5A) and resulted in dramatically reduced EB size (Fig. 3-6A and D)
and organization (Fig. 3-6B), without altering the number of observed EBs (Fig. 3-6C
and D). These changes in RA treated EBs appeared to be the result of a maintained
reduction in proliferation (Figure 3-5A) without affecting caspase 3 activity (Figure 35B) or viability (Figure 3-5C). Significantly, Nek2 overexpressing cells compared to the
control also showed reduced EB size (Fig. 3-6A and D), while showing increased
organization and an aspect ratio closer to 1 (Fig. 3-6B). Unlike the KO and KD cells,
however, pNek2-Myc transfected cells had more EBs per image area compared to
pcDNA transfected cells (Fig. 3-6C and D). Together, these data show that Nek2 is
important for regulating the cell cycle in the undifferentiated state, and it appears to
continue this regulation during the first days of neural induction.
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Figure 3-5: Nek2 deficiency inhibits proliferation without affecting apoptosis
(A) Total number of cells (B) Caspase 3 activity measured by cytoplasmic concentration
of pNA after EBs being resuspended and (C) trypan blue exclusion test measuring cell
viability in EB in wildtype (WT), Nek2 knockout (KO) and knockdown (KD) cells. N=3.
Bars represent mean values  s.e.m. P-values were determined by One-way ANOVA
with Tukey’s post-hoc analysis. ***P<0.001, ****P<0.0001.
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Figure 3-6: Altering Nek2 levels alters embryoid body development and
organization
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(A) Area, and (B) Aspect ratio (major axis/minor axis of EB from images in D formed
after 4 days of RA treatment in wildtype (WT), Nek2 knockout (KO) and knockdown
(KD) cells, and pcDNA and pNek2-Myc transfected cells. Points represent individual EB.
(C) Number of EB per image area from images in D. Points represent mean number of
EB across all images per replicate. Lines across points represent mean values  s.e.m. (D)
Phase contrast images of EB. White dotted lines outline perimeter. Scale bar = 200 m.
N=3. P-values were determined by One-way ANOVA with Tukey’s post-hoc analysis.
*P<0.5, **P<0.01, ***P<0.001, ****P<0.0001.
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3.3.3

Nek2 promotes exit from pluripotency

Since Nek2 has been explored sparingly in the context of pluripotency (Van Hoof et al.
2009) but as shown can affect cell number, the expression and protein abundance of
various factors was examined to determine if there was a relationship. RT-qPCR was
used to measure the expression of known pluripotency transcription factors Oct4 and
Nanog (Gatie et al. 2022) in undifferentiated WT, KO, and KD cells and in those
overexpressing Nek2 compared to a pcDNA control. No significant change in Oct4 levels
were detected in any condition, but there was a significant increase in Nanog expression
in KO and KD cells (Fig. 3-7A). Conversely, and relative to the control, Nek2
overexpressing cells showed a decrease in Nanog levels (Fig. 3-7B) in the
undifferentiated state. KO cells were further explored throughout RA-induced
differentiation where expression of Nanog was elevated in RA-treated cells at days 10, 14
and 17 compared to WT controls (Fig. 3-7C). Again, Nek2 overexpressing cells, relative
to the control, had reduced Nanog expression at days 0, 10 and 14 of RA treatment (Fig.
3-7D). ESRRB, a marker of pluripotency (Gatie et al. 2022), was also explored in KO
and WT cells throughout RA treatment and results showed that it was significantly higher
than the WT controls on day 10 following RA treatment, and significantly higher in KO
cells relative to WT at day 0 when RA was not present (Fig. 3-7E). In support, and
relative to the pcDNA controls, Nek2 overexpressing cells lost the ESRRB signal in
untreated cells (Fig. 3-7F). Thus, markers of pluripotency decreased when Nek2 was
overexpressed and increased with Nek2 loss, suggesting it is likely involved in
influencing the state of cell pluripotency.

144

Figure 3-7: Nek2 promotes exit from pluripotency
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RT-qPCR of pluripotency markers Oct4 and Nanog in untreated, undifferentiated (A)
wildtype (WT), Nek2 knockout (KO) and knockdown (KD) cells, and (B) pcDNA and
pNek2-Myc transfected cells. P-values were determined by One-way ANOVA with
Tukey’s post-hoc analysis. Expression of Nanog in (C) WT and KO cells and (D)
pcDNA and pNek2-Myc transfected cells during 0-17 days of RA treatment.
Immunoblotting of ESRRB in (E) WT and KO cells during days 0-17 of RA treatment
and (F) untreated pcDNA and pNek2-Myc transfected cells. P-values were determined by
Two-way ANOVA with Sidak’s post-hoc analysis or by Student’s t-test. N=3. Bars
represent mean values  s.e.m. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.
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3.3.4

Nek2 is required for neural differentiation

To test the involvement of Nek2 in neural differentiation, antibodies to -III-tubulin and
GFAP were used to detect the presence of neurons and astrocytes, respectively, in WT
and Nek2 deficient cells (KO and KD) and in cells overexpressing Nek2 (pNek2-Myc)
(Fig. 3-8). Compared to WT cells, both markers showed either reduced or absent -IIItubulin (Fig. 3-8A and B, Fig. 3-9A and B) and GFAP levels (Fig. 3-8A and C, Fig. 3-9A
and C) at days 10, 14 and 17 in KO and KD cells. Overexpression of Nek2 caused the
opposite to occur for -III-tubulin, showing a significant increase at days 10 and 17 (Fig.
3-8A and B), while GFAP levels were absent in these cells at day 17 (Fig. 3-8A). Thus,
the reduction or absence of Nek2 was sufficient to attenuate both neuronal and astrocyte
cell fates. More importantly, overexpressing Nek2 was sufficient to enhance the neuronal
fate, but it also attenuated astrocyte formation. Immunofluorescence was used to
corroborate the immunoblot findings at day 17 of RA treatment, and results confirmed no
detection of either marker in KO cells (Fig. 3-8D). To test whether or not Nek2 KO cells
remained stem-like in nature, RT-qPCR was used to detect Nestin, a neural stem cell
marker (Lendahl et al. 1990; Morshead et al. 1994; Suzuki et al. 2010). Results,
compared to undifferentiated controls, showed that Nestin expression increased in both
wildtype and KO cell lines over time (P<0.0001), however, there was no significant
difference between WT and KO cells at any of the timepoints tested (Fig. 3-8E). Thus, it
appears Nek2 is required for the differentiation of neurons and astrocytes, and its
overexpression promotes the formation of neuron but not astrocytes.
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Figure 3-8: Nek2 is required for neural differentiation
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(A) Immunoblot of neuron marker, -III-tubulin, and astrocyte marker, GFAP, in
wildtype (WT), Nek2 knockout (KO), pcDNA and pNek2-Myc transfected cells at
various times during RA treatment. Densitometry of (B) -III-tubulin and (C) GFAP
from immunoblots in A). P-values were determined by Student’s t-test. (D)
Immunofluorescence of GFAP (red), -III-tubulin (green), and DAPI (blue) staining in
WT and KO cells at day 17 of RA treatment. (E) RT-qPCR of neural stem cell marker
Nestin in WT and KO cells during days 0-17 of RA treatment. P-values were determined
by Two-way ANOVA with Sidak’s post-hoc analysis. N=3. Bars represent mean values 
s.e.m. *P<0.05, **P<0.01, ****P<0.0001.
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Figure 3-9: NEK2 knockdown blocks differentiation of neurons and astrocytes
(A) Immunoblot of neuron marker β-III-tubulin, astrocyte marker GFAP and β-actin in
wildtype (WT) and Nek2 knockdown (KD) cells after differentiation in the presence of
0.5 μM retinoic acid (RA) for 10, 14 and 17 days. Densitometry of immunoblot in A of
(B) β-III-tubulin and (C) GFAP at the same time points. Bars represent mean values 
s.e.m. N=3. P-values were determined by Student’s t-test. *P<0.05, **P<0.01,
***P<0.001, ****P>0.0001.
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3.3.5

Nek2 loss and overexpression alters Hh signalling

Canonical Hh and Wnt signalling both play an integral role in neural differentiation of
P19 cells and have been linked to Nek2 (Mbom et al. 2014; Cervenka et al. 2016; Wang
et al. 2016; Zhou et al. 2017). Wang et al. [19] and Zhou et al. [20] reported Nek2 serves
as a negative regulator of Hh signalling and our previous report has shown that
overactivation of Hh signalling through the loss of SUFU inhibited astrocyte
differentiation in the P19 model (Spice et al. 2022). Therefore, Hh signalling was first
explored as a potential mechanism for Nek2 in regulating neural differentiation. RTqPCR was performed in untreated, undifferentiated KO and KD cells, where Hh target
gene Ptch1 was increased compared to WT cells (Fig. 3-10A). However, Hh targets Gli1
and Ascl1 were only elevated in KD and not KO cells (Fig. 3-10A). A Gli-responsive
luciferase assay was also performed, which confirmed that untreated KO and KD cells
had similar Gli-luciferase activity compared to WT cells treated with 10 nM SAG (Fig. 310B). Despite the Nek2 KO and Nek2 overexpression in cells showing opposite levels of
pluripotency genes (Fig. 3-7), there was also an increase in Ptch1 expression in pNek2Myc transfected, undifferentiated cells (Fig. 3-10C). To get a better understanding how
Hh signalling may be affected by altering Nek2 levels, RT-qPCR was also performed on
Nek2-deficient and Nek2 overexpressing cells throughout RA treatment (Fig. 3-11). Nek2
KO cells showed increased expression of Gli1 at days 10 and 14 of RA treatment (Fig. 311A), whereas Nek2 overexpressing cells showed decreased expression at day 10 (Fig. 311B). In Nek2 KO cells, Ptch1 expression compared to WT controls occurred only at day
0 (Fig. 3-11C) and at later stages its amount was like that in controls. However, Nek2
overexpressing cells had reduced expression compared to the controls at day 10 of RA
treatment (Fig. 3-11D). Together, these data suggest that the presence of Nek2 acts to
reduce Hh target gene expression at these later stages, however, the link between Nek2
and Hh remains unclear as the expression of target genes was not consistent when Nek2
levels were perturbed (Figure 3-11).
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Figure 3-10: Hh and Wnt signaling are perturbed in Nek2 deficient and
overexpressing cells
(A) RT-qPCR of Hh target genes Ptch1, Gli1 and Ascl1 in wildtype (WT), knockout
(KO) and knockdown (KD) cells in undifferentiated cells. (B) Gli-responsive luciferase
assay in untreated WT, KO and KD cells and WT cells with 10 nM SAG treatment after
24 hours. (C) RT-qPCR of Hh target gene Ptch1 and Gli1 in pcDNA and pNek2-Myc
transfected cells. (D) RT-qPCR of Wnt target genes Dab2, Dkk1 and c-Myc in WT, KO
and KD undifferentiated cells. (E) β-catenin responsive luciferase assay in untreated WT,
KO and KD cells and WT cells treated with 10 nM BIO after 24 hours. (F) RT-qPCR of
Wnt target genes Dkk1 and Dab2 in pcDNA and pNek2-Myc transfected cells. P-values
were determined by One-way ANOVA with Tukey’s post-hoc analysis. N=3. Bars
represent mean values  s.e.m. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.
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Figure 3-11: Hh signaling is affected by perturbed Nek2 levels
RT-qPCR of Hh target gene Gli1 in (A) wildtype (WT) and Nek2 knockout (KO) cells,
and (B) in pcDNA and pNek2-Myc transfected cells during days 0-17 of RA treatment.
RT-qPCR of Hh target gene Ptch1 in (C) WT and KO, and (D) pcDNA and pNek2-Myc
transfected cells during days 0-17 of RA treatment. P-values were determined by Twoway ANOVA with Sidak’s post-hoc analysis. N=3. Bars represent mean values  s.e.m.
**P<0.01, ****P<0.0001.
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3.3.6

Nek2 loss and overexpression alters Wnt signalling

Since Nek2 is reported as a positive regulator of Wnt signalling through phosphorylation
of DVL and -catenin (Mbom et al. 2014; Cervenka et al. 2016), we also explored if the
canonical Wnt pathway was linked to Nek2 and neural differentiation. RT-qPCR was
performed in untreated, undifferentiated WT, KO and KD cells where the Wnt target
gene Dab2 showed no change in expression. However, other targets including Dkk1 and
c-Myc were reduced in KO cells and elevated in KD cells (Fig. 3-10D). To better
understand these differences, experiments with a -catenin-responsive luciferase assay
was performed in untreated WT, KO and KD cells and in WT cells treated with 10 nM
BIO after 24 hours. Results showed KO and KD cells had greater -catenin-luciferase
activity than WT cells, and comparable to when BIO was included as a treatment of WT
cells (Figure 3-10E). Significantly, Nek2 overexpressing cells also showed an increase in
the expression of Dkk1 and Dab2 compared to that in controls (Figure 3-10F).
Furthermore, we employed a similar strategy as that conducted for Hh signalling to
investigate the potential link between Wnt and Nek2 at later stages involving RA-induced
differentiation. RT-qPCR showed that target gene Dkk1 was increased at day 10 in KO
cells compared to WT controls (Fig. 3-12A), while Nek2 overexpressing cells showed
consistent increases in Dkk1 expression at days 0, 14 and 17 of RA treatment; the
apparent increase on day 10 was not significant (Fig. 3-12B). Dab2 was also investigated,
where KO cells showed significantly reduced expression only at day 17 compared to WT
cells (Fig. 3-12C). In contrast, when Nek2 was overexpressed in cells, Dab2 was
increased at days 14 and 17 of RA treatment (Fig. 3-12D). Thus, it appeared that the link
between Wnt signalling and Nek2 in regulating neuronal development was clearer than
Hh but still not definitive.
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Figure 3-12: Wnt signaling is affected by perturbed Nek2 levels
RT-qPCR of Wnt target gene Dkk1 in (A) wildtype (WT) and Nek2 knockout (KO) cells,
and (B) in pcDNA and pNek2-Myc transfected cells during days 0-17 of RA treatment.
RT-qPCR of Wnt target gene Dab2 in (C) WT and KO, and (D) pcDNA and pNek2-Myc
transfected cells during days 0-17 of RA treatment. P-values were determined by Twoway ANOVA with Sidak’s post-hoc analysis. N=3. Bars represent mean values  s.e.m.
**P<0.01, ***P<0.001, ****P<0.0001.
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Since Wnt1 overexpression in P19 cells promotes neuron differentiation while inhibiting
astrocyte differentiation (Tang et al. 2002) we employed a chemical strategy to further
test this relationship between Nek2 and Wnt in neurogenesis. P19 cells were treated with
BIO (Sklirou et al. 2017), an inhibitor of GSK3 that activates the Wnt pathway, and XAV
(Huang et al. 2009), a tankyrase inhibitor which serves as a Wnt pathway antagonist. Cotreating cells with RA and BIO did not alter -III-tubulin levels relative to RA alone (Fig.
3-13A and B), or when treated first with BIO before the addition of RA four days later.
RA was the key inducer as BIO alone showed little to no -III tubulin levels. The levels
of GFAP, however, was greatly affected at later stages when the canonical Wnt pathway
was activated by BIO in RA-treated cells (Figure 3-13A and C). XAV treatment,
expected to produce opposite results, showed cells co-treated with it and RA inhibited
both -III-tubulin and GFAP detection (Fig. 3-13D-F). Together, these chemical and
genetic results reveal a link between Nek2 and Wnt signalling, specifically on astrocyte
differentiation, but the mechanism is still unclear on how the loss of Nek2 attenuates
neuronal differentiation.
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Figure 3-13: Wnt is required for neural differentiation but is only sufficient to
induce neurons
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(A) Immunoblot of -III-tubulin and GFAP in wildtype cells at days 10 and 17 after
treatment with 0.5 M on days 0 and 4 (RA), 0.5 M RA with 10 nM BIO on day 0 plus
RA on day 4 (RA+BIO), 10 nM BIO treatment on day 0 (BIO) or 10 nM BIO treatment
on day 0 plus RA on day 4 (BIO+RA). Densitometry analysis of the immunoblot in A for
(B) -III-tubulin and (C) GFAP. (D) Immunoblot of -III-tubulin and GFAP in wildtype
cells at days 10 and 17 after treatment with 0.5 M RA on days 0 and 4 (RA) or 0.5 M
RA with 10 M XAV on day 0 plus RA on day 4. Densitometry analysis of the
immunoblot in D of (E) -III-tubulin and (F) GFAP. N=3. Bars represent mean values 
s.e.m. P-values were determined by Two-way ANOVA with Sidak’s post-hoc analysis.
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.
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3.3.7

Proteomic analysis identifies several differentially abundant
proteins in Nek2 deficient cells

Although canonical Hh and Wnt signalling is required in P19 cells for proper neural
differentiation (Smolich and Papkoff 1994; Tang et al. 2002; Voronova et al. 2011; Spice
et al. 2022), and there are relationships between these pathways and Nek2, our data
strongly suggests that the loss of Nek2 influences neural cell lineages linked to
pluripotency and cell proliferation. The data supports this early role, rather than being
directly linked to regulating the Wnt and Hh signalling pathways. To investigate this
further a proteomic approach comparing global protein abundance patterns was chosen to
provide more information of the pathways involving Nek2 in P19 cells. Proteins were
analyzed from cells collected at days 0, 1, 4 and 10 of RA induced differentiation of WT
and KO cells (Fig. 3-14). Differential enrichment analysis identified 1780 differentially
regulated proteins across all time points (Fig. 3-14C-F); however, only 3 proteins were
upregulated in KO cells (Fig. 3-15A): Cth, Slc25a13 and Pla2g15. In exploring pathways
enriched specifically at day 10 of RA treatment, KO cell pathway enrichment included
proteins involved in fatty acid metabolism, the G2 DNA damage checkpoint and K63
linked deubiquitination (Fig. 3-15C). Sixteen proteins were found to be downregulated in
KO cells (Fig. 3-15B), including Ndufb8, Ndufv1, Ndufa10, Ndufc2, Mtnd4, Ptgr1,
Mtnd1, Ndufs1, Mtco2, Ndufa4, Ndufa12, Ndufa5, Ndufb1, Cox6b1, Mtnd5 and Gstp1,
and pathway enrichment in WT cells included proteins involved in negative regulation of
cell projection organization, negative regulation of neuron projection development and
mitochondria localization (Fig. 3-15D). Other pathways enriched in the WT population
include Myc targets, epithelial to mesenchymal transition proteins and those related to
oxidative phosphorylation (Fig. 3-14G).
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Figure 3-14: LC-MS workflow and results of WT and KO cells
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(A) Workflow of LC-MS. (B) Principal component analysis of samples used for LC-MS
showing clustering of biological replicates. Proteins identified as up or down regulated in
KO cells compared to WT cells at days (C) 0, (D) 1, (E) 4 and (F) 10 of RA treatment.
(G) GSEA Pathway Enrichment Analysis of proteins enriched in WT cells compared to
KO cells.
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Figure 3-15: Loss of Nek2 inhibits oxidative metabolism
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Proteins identified through LC-MS that are (A) upregulated and (B) downregulated in
KO cells compared to WT cells at days 0, 4 and 10 of RA treatment. GSEA enrichment
analysis of LC-MS results identifying pathways that are (C) enriched in KO cells
compared to WT cells and (D) in WT cells compared to KO cells at day 10 of RA
treatment. (E) Immunoblot of electron transport chain components, SDHB, MTCO1,
UQCRC2 and ATP5A corresponding to subunits in complexes II-V, respectively, in WT
and KO cells at days 0 and 4 of RA treatment. (F) Densitometry analysis of immunoblots
in E. P-values were determined by One-way ANOVA with Tukey’s post-hoc analysis.
Phase contrast images and viability of cells determined through trypan blue exclusion in
cells treated with (G) media only or 50 mM 2-DG, and (H) DMSO or 2.5 M oligomycin
A for 24 hours. Scale bar = 200 m. P-values were determined by Two-way ANOVA
with Sidak’s post-hoc analysis. Immunoblot of HIF1 in untreated and RA treated (I)
WT and KO cells and (J) pcDNA and pNek2-Myc transfected cells. (K) Proposed
mechanism of Nek2 action. Image created using BioRender. Bars represent mean values
 s.e.m. **P<0.01, ***P<0.001, ****P<0.0001.
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3.3.8

Loss of Nek2 promotes glycolytic metabolism

Since most proteins negatively impacted in Nek2 KO cells involved complexes of the
mitochondrial electron transport chain (ETC) and that WT cells compared to KO cells at
day 10 had enriched proteins related to oxidative phosphorylation (OxPhos; Fig. 3-14),
we wanted to test what metabolic pathway was being utilized in Nek2 KO cells.
Immunoblotting was used and like the LC-MS results, results showed KO cells at days 0
and 4 of RA treatment had reduced or absent ETC complexes II, III and IV (Fig. 3-15E
and F). Furthermore, these cells were treated with either 50 mM 2-deoxy-D-glucose (2DG) to inhibit glycolysis, or 2.5 M oligomycin A to inhibit OxPhos to determine if,
compared to WT cells, they were reliant on one or the other metabolic pathways. Results
showed WT cell viability was unaffected by either treatment (Fig. 3-15G and H,
respectively) suggesting these cells likely have a bivalent metabolism in the
undifferentiated state. However, 2-DG significantly reduced KO cell viability (Fig. 315H), implying these cells rely on glycolysis. As glycolytic genes are known to be
upregulated in response to hypoxia-inducible factor 1 (HIF1) stabilization (Kierans
and Taylor 2021), we explored HIF1 levels in untreated, undifferentiated WT and KO
cells (Fig. 3-15I) and in cells overexpressing Nek2 (Fig. 3-15J). Under normoxic
conditions, undifferentiated WT cells do not show HIF1 stabilization at days 0 or 10 of
RA treatment, whereas KO cells did show stabilization at these same timepoints (Fig. 315I). Nek2 overexpressing cells showed very little HIF1 stabilization at day 0 but was
not different from pcDNA transfected controls at either timepoint (Fig. 3-15J). These
results show that Nek2 is essential for maintaining ETC components and that the loss of
Nek2 shifts P19 cells towards glycolysis and sustained HIF1 stabilization (Fig. 3-15K).
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3.4

Discussion

Nek2 has many roles within the cell and is involved in regulating centrosome dynamics,
signaling pathways and metabolism, and although its importance is clear, few studies
have explored this protein within normal development (Tanaka et al. 1997; Joseph
Endicott et al. 2015a; Martins et al. 2017). We have shown that Nek2 is essential in the
differentiation of both neurons and astrocytes in the P19 embryonal carcinoma model
(Fig. 3-8 and 3-9) and previous reports have placed Nek2 as a regulator of the Hh and
canonical Wnt pathways (Mbom et al. 2014; Cervenka et al. 2016; Lin et al. 2016; Wang
et al. 2016; Zhou et al. 2017), which are required in this process (Schuuring et al. 1989;
St-Arnaud et al. 1989; Papkoff 1994; Tang et al. 2002; Voronova et al. 2011; Spice et al.
2022) (Fig. 3-13). Towards that end, we sought to explore neural differentiation using the
P19 model through the context of Wnt and Hh signaling, and although Nek2 appears to
affect these pathways, the data did not indicate that their deregulation was the causative
factor affecting neural differentiation. We did find that a reduced proliferative capacity of
cells lacking Nek2 (Fig. 3-4 and 3-5) and a metabolic shift away from OxPhos towards
exclusively glycolytic metabolism (Fig. 3-15) as the likely cause of this reduced
differentiation potential when Nek2 is absent.
One of the main factors seeming to affect the differentiation of neurons and astrocytes
was the reduced proliferative capacity of Nek2 KO cells. Without Nek2, undifferentiated
cells had reduced numbers (Fig. 3-4) as did cells in EBs, where these EBs had reduced
size and organization (Fig. 3-6) without altered cell viability or apoptosis (Fig. 3-5).
Interestingly, the overexpression of Nek2 resulted in the opposite phenotype, with
increased proliferation in the undifferentiated state (Fig. 3-4) and reduced EB size, but
increased EB number (Fig. 3-6). The loss of Nek2 was also reported to cause reduced
proliferation in glioblastoma and medulloblastoma cell lines, however, this reduction was
accompanied by increased apoptosis (Boulay et al. 2017; Xiang et al. 2022). Another
report also observed the reduced ability of Nek2-depleted cells to form spheroids (similar
to EBs) in a hepatocellular carcinoma cell line (Lin et al. 2016). This study by Lin et al.
(Lin et al. 2016) also showed Wnt3a treatment resulted in an increase in spheroid number
in Nek2 expressing hepatocellular carcinoma cells, which parallels our results that
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showed when Nek2 was overexpressed it caused canonical Wnt signaling to be activated
(Fig. 3-12) and an increased number of EB (Fig. 3-6). Despite the well-known
phenomenon that pluripotent cells are highly proliferative (Liu et al. 2019), we were
surprised that unlike hepatocellular carcinoma cells depleted of Nek2 (Lin et al. 2016),
our KO cells showed elevated pluripotency factors, Nanog and ESRRB (Fig. 3-7), and
reduced proliferation rates (Fig. 3-4 and 3-5). These pluripotency factors were also
reduced or absent when Nek2 was overexpressed in P19 cells (Fig. 3-7), and this was
accompanied by an increase in proliferation (Fig. 3-4). Despite the lack of information
reported for Nek2, these differences in pluripotency and proliferation were noted but their
significance remains unknown. A previous report in hESCs identified Nek2 activity in
the undifferentiated state and during early induction of differentiation (Van Hoof et al.
2009), which highlights that Nek2 is likely playing a role, however the specifics of its
role in pluripotency are unclear. Our results, with this previous report (Van Hoof et al.
2009), note Nek2 is likely functioning earlier during the “decision-making" process
involving pluripotency (Fig. 3-7) and/or cell fate determination that favors one lineage
over the other (Fig. 3-8 and 3-9). Although we predicted the role of Nek2 lay within
regulation of Wnt or Hh, our results point to the regulation of pluripotency and the
unlikelihood that Nek2 in P19 cells is directly linked to Hh (Fig. 3-11) and/or canonical
Wnt signaling (Fig. 3-12) in differentiation.
In addition to changes in pluripotency factors a proteomics approach revealed several
proteins with differential enrichment in WT and KO cells and highlighted a reduction in
mitochondrial ETC components in Nek2 KO cells (Fig. 3-15). Further experiments,
confirming these LC-MS results, showed that losing Nek2 altered cellular metabolism,
with KO cells becoming exclusively glycolytic (Fig 3-15). Experiments are underway
using other cell lines to determine if Nek2 KO influences cellular metabolism, especially
in the light of the study by Zhou et al. (Zhou et al. 2021) who found in certain types of Bcell lymphomas that Nek2 promotes proliferation but also glycolysis. We explored
HIF1 levels and results showed P19 cells lacking Nek2 showed increased HIF1
stabilization (Fig. 3-15I) and a concomitant reliance on glycolytic metabolism (Fig. 315G). The connection between metabolic changes and neural differentiation has been
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reported in human induced pluripotent stem cell (hiPSC) derived neural precursors
(NPCs) where there is a switch from aerobic glycolysis to OxPhos in neurons involving
pyruvate kinase M1/2 (PKM) isoforms (Zheng et al. 2016). Given that Nek2 is also
involved in PKM splicing (Gu et al. 2017; Zhou et al. 2021) and its loss causes P19 cells
to become glycolytic (Fig. 3-15) and thus blocking neural differentiation (Fig. 3-8 and 39), it seems reasonable to propose its contribution in this process. HIF1 has also been
explored within neural differentiation where its overexpression in hiPSCs enhanced
pluripotency and reduced neural differentiation (Cui et al. 2021), which was also
observed in mESCs (Večeřa et al. 2017). Previous work with P19 cells has shown that
there is a shift from glycolytic metabolism to OxPhos with RA induction and this
promotes neuron differentiation (Vega-Naredo et al. 2014; Pashkovskaia et al. 2018).
Interestingly, and in contrast to our proposed mechanism of cells grown under normoxic
conditions (Fig. 3-15J), a previous report in P19 cells showed an increase in neuron
differentiation under hypoxic conditions where HIF1 was stabilized (Wu et al. 2008).
Given our work, however, we have shown in P19 cells that altered metabolism and neural
differentiation is the result of cells lacking Nek2, thus demonstrating an essential role for
Nek2 in regulating this metabolic transition from glycolysis to OxPhos. Evidence would
suggest the mechanism of Nek2 regulation likely involves HIF1, however the direct link
between Nek2 and it remains to be established (Fig. 3-15J). These connections, in
addition to the post-translational modifications Nek2 likely performs to promote or
inhibit neural differentiation must be further examined and are currently under
investigation.
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Chapter 4

4

Discussion & Conclusions
4.1

Summary of Key Findings

Neural development and differentiation require many signaling pathways and protein
interactions to give rise to the distinct cell types of the central nervous system. Hh and
Wnt signaling are two of the pathways that regulate this process, however, each pathway
has many unique and overlapping players that act to regulate transcriptional output.
Included in this group are SUFU and Nek2, which have distinct roles in neural
differentiation, but their function(s) are not entirely understood or have never been
explored. Within this work I hypothesized that if Hh and Wnt signaling are required in
the RA-induced differentiation of P19 embryonal carcinoma cells, then loss of function
of either SUFU or Nek2 would disrupt the regulation of these signaling pathways and
block the differentiation of neural lineages.
In Chapter 2, I determined the timing of Hh signaling activity in P19 cells and sought to
establish if Hh signaling is sufficient to induce differentiation and whether genetic
ablation of SUFU would block differentiation. Through the investigation of Gli1 target
gene expression and the Gli3 full-length to repressor ratio, I determined that Hh signaling
increases its activity one day after RA induction before returning to basal levels. Thus,
Hh signaling is temporally regulated during P19 neural differentiation. To test if this
activity is required for differentiation, I used a chemical activator and an inhibitor of the
Smo transmembrane protein, that when active transduces the Hh signal. Co-treatment of
P19 cells with RA and SAG, the activator, increased the differentiation of both neurons
and astrocytes. However, SAG treatment alone was not sufficient to induce robust
differentiation of either cell type. Conversely, co-treatment of cells with RA and the
inhibitor, Cyc, reduced differentiation of neurons and blocked the formation of
astrocytes. These results confirmed that Hh signaling is required to induce neural
differentiation, however, Hh activity alone was not sufficient. The genetic loss of
function in the Sufu gene using CRISPR provided evidence that the reduction of Hh
signaling after neural induction was required. These experiments confirmed SUFU as a
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negative regulator of the Hh pathway and SUFU loss increased Hh target gene expression
throughout RA-induced differentiation. In fact, this increased target gene expression was
linked to the loss of the Gli3 transcription factor, a negative transcriptional regulator
(Altaba 1998; Bai et al. 2002; Buttitta et al. 2003; Motoyama et al. 2003). The loss of
SUFU, and subsequent loss of Gli3 corresponding to the overactivity of Hh target gene
expression, resulted in delayed and decreased astrocyte differentiation. However, this did
not affect neuron differentiation. Given this data I concluded that Hh is required for
neural differentiation, and at later stages the reduction of Hh signaling is also required for
the proper timing and proportion of astrocyte differentiation.
Nek2 is another negative regulator of Hh signaling (Wang et al. 2016; Zhou et al. 2017).
However, this protein has not been well studied in neural development. Nek2 regulates
Hh signaling through SUFU (Wang et al. 2016) and given my discovery that SUFU is
key in neural differentiation of P19 cells (Chapter 2), I predicted removing Nek2 using
CRISPR would have similar effects (Chapter 3). Nek2, however, is also a positive
regulator of canonical Wnt signaling (Mbom et al. 2014; Cervenka et al. 2016), a
pathway required for neural differentiation of P19 cells. The presence and expression of
Nek2 was confirmed in P19 cells, and in addition to the CRISPR studies, I used plasmid
vectors to overexpress human Nek2 in these cells. Changes in proliferation were
identified as a major determinant from these studies, where loss of Nek2 reduced
proliferation while overexpression had a profound increase that translated into changes in
embryoid body formation. Given these changes, I explored if pluripotency genes were
affected and surprisingly found that the loss of Nek2 corresponded to an increase in the
abundance of pluripotency markers; Nek2 overexpressing cells showed reduced
expression. Hh and Wnt target gene expression was also explored in Nek2-/- cells and
although there were changes in Hh target gene expression, they were inconsistent and did
not reveal a clear connection between Nek2 and Hh signaling. Wnt target genes showed
similar inconsistencies in Nek2-decificent cells but were consistently upregulated in Nek2
overexpressing cells. These same cells showed enhanced neuron differentiation at the
expense of astrocytes, while P19 cells treated with XAV and expected to show little to no
Wnt target gene expression, also showed reduced astrocyte differentiation. This data
confirmed Nek2 as a positive regulator of Wnt signaling in neural differentiation. It is
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interesting to note, cells lacking Nek2 did not differentiate into neurons or astrocytes,
although they did express Nestin, a neural precursor marker. Since the results with Nek2
and Hh or Wnt signaling were confusing, I pursued a proteomics approach to examine the
large-scale changes in protein abundance that exist between wildtype and Nek2-/- cells.
These data suggested Nek2 in P19 cells is involved in the regulation of cellular
metabolism and I determined that cells deficient of Nek2 caused the loss of mitochondrial
electron transport chain components. Given these metabolic changes I also explored
HIF1, where levels of this protein were found to increase in Nek2-deficient cells.
Together, these data suggested a model of Nek2 regulation of differentiation, where
through a currently unknown mechanism, Nek2 promotes the destabilization of HIF1
and allows cells during later stages of differentiation to transition from a primarily
glycolytic metabolism to oxidative phosphorylation. Although this process is required for
neural differentiation, it may be more a general phenomenon in cells requiring this
transition during lineage specification.
The presented work, shown as a model in Figure 4-1, confirms the requirement of both
Hh and Wnt signaling in neural differentiation, and I have shown that SUFU, a negative
regulator of Hh signaling, is essentially linked to the process. Furthermore, my data
suggests Nek2 does not act as a regulator of the Hh signaling pathway. Instead, Nek2 acts
much earlier, on metabolism and a model is presented that the protein is required for the
transition of cells using glycolysis to ones using oxidative phosphorylation to generate
ATP. Together, and despite cell specification and neural development having been
extensively explored, this work provides evidence that the role of specific regulators of
signaling, and metabolism are intricately linked in developing cells.
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Figure 4-1: Model for the role of SUFU and Nek2 in P19 neural differentiation
In the process of a cell exiting pluripotency and becoming a neural stem cell, Hh
signaling is activated early in this process (Chapter 2). Nek2 plays a role in this process
by promoting the exit from pluripotency, while cells can become neural stem cells while
being using exclusively glycolytic metabolism (Chapter 3). Neurons can differentiate in
the presence of overactive Hh signaling (Chapter 2) and overactive Wnt signaling
promotes neuron differentiation (Chapter 3). SUFU is required to return Hh signaling to
basal levels to facilitate astrocyte differentiation (Chapter 2). Nek2 is required for the
differentiation of both neurons and astrocytes to facilitate the switch from glycolysis to
OxPhos (Chapter 3).
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4.2
4.2.1

Discussion & Significance
Stem cell models of neural differentiation

The embryonal carcinoma cell line, mouse P19, was used in this work as an easy to
manipulate model to study the molecular mechanisms of neural differentiation in vitro.
Like P19 cells, embryonic stem cells (ESCs), cells derived from the inner cell mass of a
blastocyst (Evans and Kaufman 1981), can also undergo neural differentiation. Initial and
subsequent studies of ESC neural differentiation, like P19 cells, relied on cell aggregation
in the presence of RA (Bain et al. 1995), however, some later protocols have been
established to derive neural lineages in the absence of both aggregation and RA using
specific serum-free media conditions (Ying et al. 2003; Abranches et al. 2009). Although
these later protocols are in monolayer conditions, tight cell clustering is still required for
neural induction of ESCs as the cells in these studies must form rosettes for
differentiation to occur (Ying et al. 2003; Abranches et al. 2009). Interestingly, the
neuroectodermal cell fate appears to be the default program in ESCs as simply the
removal of Leukemia Inhibitory Factor (LIF), a chemical required to maintain ESCs in
their pluripotent state (Silva et al. 2008; Wulansari et al. 2021), is sufficient to form
rossettes and neural progenitors (Ying et al. 2003). Not only can ESCs be used to derive
immature neurons and glial cells, but they can also be directed towards specific types of
neurons from various brain regions. P19 cell differentiation allows for a heterogeneous
mixture of undirected neuron differentiation in the presence of RA, whereas human ESCs
(hESCs) and mouse ESCs (mESCs) can be induced to form midbrain dopaminergic
neurons (Kawasaki et al. 2000; Perrier et al. 2004), motor neurons (Hu and Zhang 2010),
cortical neurons (Gaspard et al. 2009), and GABAergic neurons (Gonzalez-Ramos et al.
2021) more homogenously under specific culture conditions. Given the relative
homogeneity of ESC neural differentiation conditions, ESCs have been used to study the
role of histone regulation and epigenetics (Golebiewska et al. 2009; Yao et al. 2018),
extracellular matrix components (Hashemi et al. 2013), and mitochondrial electron
transport (Pereira et al. 2013) in neural differentiation. ESCs have also been used to
explore how environmental toxins affect neural differentiation (He et al. 2012; Shan et al.
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2021) and have provided a means to link basic biology with biotechnology (Kabiri et al.
2012). Similarities exist between the presented data using P19 cells and ESCs, as hESCs
increase expression of Hh ligands with neural induction (Wu et al. 2010) and exogenous
SHH similarly increases neural differentiation (Fraichard et al. 1995; Mak et al. 2012).
Conversely, Hoelzl and colleagues derived mESCs carrying a Sufu knockout and showed
no reported changes to the ectodermal lineage (Hoelzl et al. 2015), however specific
markers for neural cell types were not explored. Additionally, ESC studies form the basis
of understanding the metabolic switch from glycolysis to OxPhos during neuron
differentiation (Zheng et al. 2016) and shows similar connections to HIF1
overexpression and reduced neuron differentiation (Cui et al. 2021). Although ESC
models are likely to continue to hold a prominent position in the future of studying neural
differentiation, there will remain a place for embryonal carcinoma cells as they require
fewer reagents and are less costly to maintain (Jones-Villeneuve et al. 1982; Witteveldt
and Macias 2019). For example, P19 cells can be cultured in standard cell culture media
and maintain their pluripotency, while mESCs require Wnt and MAPK inhibitors in
addition to being cultured in LIF containing media (Witteveldt and Macias 2019). Using
P19 cells as a launch point for early investigations into molecular mechanisms of neural
differentiation, as they were used for my work, is essential for many labs before
translating that work into more costly ESC or in vivo mouse models.

4.2.2

SUFU is required to regulate Hh signaling during astrocyte
differentiation

Hh signaling is known to play an important role in neuron and glial cell differentiation
(Chiang et al. 1996; Ericson et al. 1996, 1997; Litingtung and Chiang 2000) and SUFU,
acting as a negative regulator of signaling, is also required (Spice et al., 2022). SUFU
acts to promote the phosphorylation of Gli3 (Kise et al. 2009), the primary transcriptional
repressor of the Hh pathway (Altaba 1998; Bai et al. 2002; Buttitta et al. 2003;
Motoyama et al. 2003). In my thesis I showed the essential role of SUFU in astrocyte
differentiation, specifically its regulation of Gli3 (Chapter 2). In the absence of SUFU, I
showed that the full-length and repressor forms of Gli3 were reduced or lost, and Hh
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target gene expression was elevated (Chapter 2). This observation is supported by other
in vitro models and in the developing mouse brain where Sufu-/- caused a reduction in
Gli3 and overactivation of Hh signaling (Chen et al. 2009; Kim et al. 2011, 2018; Makino
et al. 2015; Yabut et al. 2015; Jiwani et al. 2020).
Temporal regulation of Hh signaling is key to the proper timing and number of
differentiated cell types (Agius et al. 2004; Ribes and Briscoe 2009). I demonstrated that
Hh pathway activity is regulated temporally in the P19 model, where SUFU loss of
function disrupted this regulation (Chapter 2). The constitutive overexpression of Hh
target genes in SUFU-deficient cells did not affect the number of neurons (Chapter 2),
which was unexpected as I and others have shown that exogenous SHH or SAG treatment
increases neuron formation (Chapter 2) (Okada et al. 2004; Mak et al. 2012; Wu et al.
2012). It is interesting to note that the loss of Sufu in the adult or developing mouse brain
results in decreased neuron differentiation (Yabut et al. 2015; Kim et al. 2018). Thus,
SUFU likely plays multiple roles within the cell during neuron differentiation and more
work is needed to completely understand its role. Similarly, additional studies are
required to explore the intracellular localization and protein-interaction partners of SUFU
in normal neuron differentiation. SUFU has many reported interacting proteins (PacesFessy et al. 2004) and posttranslational modifications can promote or inhibit Gli
interactions (Takenaka et al. 2007; Chen et al. 2011; Wang et al. 2016; Infante et al.
2018).
The major finding of Chapter 2 was the reduced and delayed differentiation of astrocytes
corresponding to overactive Hh signaling caused by SUFU loss. Astrocyte differentiation
is regulated by Hh signaling by specifying astrocyte progenitors, but Hh activity needs to
be reduced to facilitate terminal astrocyte differentiation. In chick spinal cord explants,
exogenous SHH treatment reduces GFAP-positive astrocytes (Agius et al. 2004), while
glial progenitors increase (Li et al. 2019). These results are supported by Smo-/- in the
adult mouse forebrain, which causes increased GFAP levels (Garcia et al. 2010). In this
same study the number of S100 expressing astrocytes was unaffected (Garcia et al.
2010), like the expression pattern of S100 I observed in SUFU-deficient cells (Chapter
2). The study by Garcia et al. 2010, like mine, suggest that SUFU is only required for the
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detection and differentiation of GFAP-positive astrocytes. In contrast, SHH increased
astrocyte differentiation of NG2 progenitor cells in the adult mouse brain after focal
cerebral ischemia (Honsa et al. 2016). These differences, however, are likely due to the
injury rather than normal development. If SUFU-deficient cells are not properly
differentiating as astrocytes, and are still differentiating into neurons, what are the
remaining cell types in the dish? Although not explored in the presented work, I can
envision these cells are either blocked as astrocyte precursors or are being converted to
oligodendrocyte precursor cells. Active Shh signaling is reported in astrocyte precursor
cells (Yu et al. 2013) and exogenous SHH treatment of mature astrocytes during
reprogramming to a precursor phenotype enhances this efficiency (Yang et al. 2019). Hh
signaling also promotes oligodendrocyte differentiation in the telencephalon (TekkiKessaris et al. 2001) and in primary oligodendrocyte progenitor cultures (Wang and
Almazan 2016), where loss of Sufu promotes terminal oligodendrocyte differentiation
through overactive Hh signaling (Winkler et al. 2018). More support for the prediction
that SUFU-deficient P19 cells are committing to the oligodendrocyte lineage comes from
Pozniak and colleagues, who show that Sox10 directly binds the promoter region of Sufu
to block its expression and promote oligodendrocyte precursor specification (Pozniak et
al. 2010). These reports underscore the idea that more work will be required in P19 cells
to determine if astrocyte differentiation is impaired when SUFU is deficient and if this
leads to an increase in the oligodendrocyte progenitor pool. Another possibility to explain
the observed reduced astrocyte differentiation in SUFU-deficient cells could lie outside
of the neural lineage. P19 cells are a heterogenous mixture of neural cells and
uncharacterized fibroblast-like cells following RA treatment (Jones-Villeneuve et al.
1983), where it remains a possibility that the SUFU-deficient cells could more readily
become this uncharacterized cell type. Additionally, SUFU loss may be affecting neuronglial progenitor cell-cell communication. It is reported that differentiated neurons secrete
factors that affect the timing of gliogenesis (Barnabé-Heider et al. 2005), thus it is also
possible that although the loss of SUFU did not alter neuron differentiation it may have
altered the proteins secreted by neurons which could alter astrocyte differentiation. This
cell-cell communication would also be impacted by the types of neurons being
differentiated with SUFU knockout, an avenue of investigation that was not explored in
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the presented work. Given the heterogeneity of RA induced P19 neural differentiation,
the model I describe to explain these presented data is but one possibility, and more work
should be done to determine if the loss of SUFU is causing changes to the potential or
identity of the glial progenitor pool, or if the neurons are driving the reported changes.
Although the role of SUFU has been extensively studied in neural development, my work
places SUFU as an essential regulator of oligodendrocyte and astrocyte differentiation.

4.2.3

Nek2 regulates metabolism during neural specification

Regulation of metabolism is intricately linked to pluripotency and cell differentiation.
Pluripotent ESC and embryonal carcinoma cell lines use glycolysis or are bivalent,
showing both glycolytic and oxygen-dependent metabolisms, to generate energy (VegaNaredo et al. 2014; Gu et al. 2016; Shyh-Chang and Ng 2017; Pashkovskaia et al. 2018;
Spice et al. 2022). It is generally accepted that the loss of pluripotency and the induction
of a terminally differentiated fate coincides with a switch from either a glycolytic or
bivalent metabolism to one using exclusively oxidative phosphorylation (OxPhos) (Gu et
al. 2016; Shyh-Chang and Ng 2017). This holds true during neuron differentiation, where
hiPSC derived neural precursors switch from aerobic glycolysis to OxPhos during
terminal neuron differentiation (Zheng et al. 2016). This metabolic shift is also seen in
P19 cells, where promoting OxPhos increases neuron differentiation, while inhibiting it
reduces the number of neurons (Vega-Naredo et al. 2014; Pashkovskaia et al. 2018).
Metabolism plays many roles in regulating differentiation by altering the presence of
metabolites, such as lactate (Gatie et al. 2022), which can act as signaling molecules.
Manipulating the levels of reactive oxygen species in the cell (Bigarella et al. 2014), and
the availability of epigenetic modifying molecules generated through metabolic
processes, can alter transcriptional output that influences cell fate and differentiation
(Harvey et al. 2019). I showed that ablating Nek2, a known cell cycle regulator (Fry
2002; Rellos et al. 2007; Cervenka et al. 2016; Sahota et al. 2018), and Hh signaling
modulator (Wang et al. 2016; Zhou et al. 2017), in P19 embryonal carcinoma cells
caused them to rely on aerobic glycolysis and to lose the expression of mitochondrial
electron transport chain components (Chapter 3). These cells also lost the ability to
differentiate to neuron or astrocyte lineages, but were still expressing a neural precursor
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marker, Nestin (Chapter 3). Previous reports with P19 cells exploring metabolism only
reported on the effect of OxPhos inhibition on neuron differentiation (Vega-Naredo et al.
2014; Pashkovskaia et al. 2018), where I propose blocking OxPhos also inhibits astrocyte
differentiation (Chapter 3). Given mature astrocytes are primarily glycolytic (Rose et al.
2020), it is possible these cells require a transient switch to OxPhos, but also may point to
an essential neuron-astrocyte precursor communication link. The Nek2-mutant cell
reliance on glycolysis is likely blocking neuron differentiation, while the loss of neurons
may be causing the loss of astrocyte differentiation through the loss of currently unknown
signaling molecule(s) secreted from terminally differentiated neurons. These questions
were not further explored in this work, but I did explore a potential link between
glycolysis and Nek2 through HIF1, a known activator of glycolytic gene expression
(Sharp and Bernaudin 2004).
Under normoxic conditions HIF1 is constitutively expressed but is rapidly degraded by
the proteosome (Sharp and Bernaudin 2004; Cunningham et al. 2012). The
destabilization of HIF1 is usually performed by hydroxylases (Cunningham et al. 2012),
however, it can also be performed by kinases (Mennerich et al. 2014), including GSK3.
The activity of GSK3 has been reported to reduce HIF1 stabilization in COS7 cells,
ovarian cancer cells and hepatocellular carcinoma cells (Sodhi et al. 2001; Flügel et al.
2007; Cassavaugh et al. 2011). Toward that end, I proposed a mechanism in P19 cells
whereby Nek2 promotes destabilization of HIF1, causing OxPhos genes to increase
their expression and promote the transition from neural precursors to neurons and
astrocytes (Chapter 3). Although the direct link between Nek2 and HIF1 has yet to be
established, the GSK3 data suggests that Nek2 may directly or indirectly be involved
with this process. GSK3 can also phosphorylate SUFU (Chen et al. 2011), like Nek2
(Wang et al. 2016). Thus, HIF1 may be another shared target of these kinases and a
decrease in Nek2 activity (or as evident by the loss of Nek2, this study), would promote
HIF1 stabilization. HIF1 stabilization was found to accompany pluripotency in these
cells and neural differentiation, occurring after neural precursor induction, is inhibited
(Chapter 3). In support, embryonic and adult neural stem cells are reliant on glycolysis
over OxPhos (Candelario et al. 2013), and there is stabilization of HIF1 (Panchision
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2009; Li et al. 2014; Zhao et al. 2014). In addition, HIF1 loss of function in the mouse
brain also causes reduced neural differentiation, which is directly linked to a reduced
neuronal precursor pool (Tomita et al. 2003; Li et al. 2014). Although the link between
Hh and Wnt signaling pathways and Nek2 showed no clear connection (Chapter 3),
players in Notch signaling may be involved. Gustafsson et al. (2005) reported HIF1
directly interacts with the intracellular domain of the cleaved Notch receptor to promote
the expression of stem-related genes. Thus, I propose in P19 cells the loss of Nek2
function accompanied by HIF1 stabilization, leads to the latter interacting with active
Notch to promote the increase in pluripotency markers (Chapter 3) and inhibit neural
differentiation (Panchision 2009). No evidence currently exists showing this interaction
in P19 cells, but it is possible, and testing is required. Another connection between Nek2
and HIF1 exists at the level of PKM2, pyruvate kinase M2. Nek2 is reported to regulate
the PKM1 to PKM2 splicing switch (Gu et al. 2017; Zhou et al. 2021), while HIF1 is
reported to bind PKM2 to promote HIF1 related transcription (Semenza 2011). The role
of Nek2 within neural differentiation, pluripotency and regulation of metabolism is still
unclear, however this work provides numerous platforms for future studies.

4.3

Limitations & Future Directions

The presented work confirms the role of Hh and Wnt signaling in neural differentiation
and highlights new roles for SUFU in astrocyte differentiation, and Nek2 in neuron and
astrocyte differentiation. The P19 cell model used to explore these questions, has its
benefits and they have been previously discussed, but they are not stem cells per se and
therefore not completely reminiscent of the embryo. Exploring neural differentiation and
applying these same questions in human and/or mouse ESC will be necessary to fully
appreciate the role of these protein regulators during development. Despite the extensive
body of work that has already been reported for SUFU in P19 and ESCs (Wu 2010;
Voronova et al. 2011; Hoelzl et al. 2015), much remains about the post-translational
modifications and subcellular localization of SUFU during differentiation. Conversely,
Nek2 has not been reported in mammalian neural differentiation, and this future work in
ESC lines is required to corroborate my initial studies. Another limitation of the
presented work, and a limitation with all cell lines, is the reduced complexity compared
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to the embryo. Three-dimensional culture is partially replicated in this work as cells are
required to be cultured as embryoid bodies for differentiation to occur (Jones-Villeneuve
et al. 1982). Although organoids are a better in vitro system for studying neural
differentiation within a 3D context, they too have limitations. Although not ideal, the
packaging of P19 cells into embryoid bodies, and not in the embryo itself, likely
recapitulates enough 3D complexity to create conditions required for transient
stabilization of HIF1 in neural progenitors (Panchision 2009; Li et al. 2014; Zhao et al.
2014).
The stabilization of HIF1 in Nek2-deficient cells (Chapter 3) was an exciting discovery,
as it linked the observed changes in metabolism to a known metabolic regulator. Nek2
was reported as a regulator of centrosome dynamics (Fry 2002; Rellos et al. 2007;
Cervenka et al. 2016; Sahota et al. 2018); however, I have shown its involvement in
regulating neural differentiation through metabolism (Chapter 3). Others have linked
Nek2 to metabolism through PKM1/2 splicing (Gu et al. 2017; Zhou et al. 2021), but
whether Nek2 directly interacts with HIF1 remains to be determined. Loss of Nek2 also
caused a reduction in electron transport chain components (Chapter 3) and although
HIF1 may be involved in these changes, the exact mechanism involving Nek2 remains
unknown. Chromatin-immunoprecipitation studies of HIF1 in Nek2-deficient cells must
be undertaken to determine if this protein is regulating the expression of the electron
transport chain subunits. Additionally, the proteomic data presented in Chapter 3 show
multiple pathways are enriched in Nek2 deficient cells and these must be explored.
Together, establishing a Nek2 interactome would be ideal to better understand the various
roles of this protein. The strategy used in this thesis was based on the literature, and
experiments were designed to explore Nek2 and its relation to Wnt and Hh signaling.
Unfortunately, the results showed no connections between these pathways and the Nek2
protein, and I would suggest that co-immunoprecipitation studies, followed by mass
spectrometry, must also be performed to provide an understanding of the proteins that
interact with Nek2.
Neural differentiation has been studied now for decades, however, there is still much that
is unknown about the signaling pathways and proteins that govern this process. Although

185

my work has limitations and proposes new questions that have yet to be answered, it
nevertheless provides us with a better understanding of the complex processes required to
specify neural cell types.
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